<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Other Carbon-Nitrogen Bond-Forming Biotransformations 5.1 Biocatalytic N-Acylation of Anilines in Aqueous Media</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Anna</forename><surname>≈ªa Àõd≈Ço-Dobrowolska</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Institute of Organic Chemistry</orgName>
								<orgName type="institution">Polish Academy of Sciences</orgName>
								<address>
									<settlement>Warsaw</settlement>
									<country key="PL">Poland</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolfgang</forename><surname>Kroutil</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Chemistry</orgName>
								<orgName type="institution" key="instit1">University of Graz</orgName>
								<orgName type="institution" key="instit2">NAWI Graz</orgName>
								<address>
									<addrLine>BioTechMed Graz</addrLine>
									<settlement>Graz</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Austrian Centre of Industrial Biotechnology</orgName>
								<orgName type="department" key="dep2">acib GmbH</orgName>
								<address>
									<settlement>Graz</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><surname>Co</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Chemistry</orgName>
								<orgName type="institution" key="instit1">University of Graz</orgName>
								<orgName type="institution" key="instit2">NAWI Graz</orgName>
								<address>
									<addrLine>BioTechMed Graz</addrLine>
									<settlement>Graz</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Ho</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Institute of Chemistry</orgName>
								<orgName type="institution" key="instit1">University of Graz</orgName>
								<orgName type="institution" key="instit2">NAWI Graz</orgName>
								<address>
									<addrLine>BioTechMed Graz</addrLine>
									<settlement>Graz</settlement>
									<country key="AT">Austria</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Other Carbon-Nitrogen Bond-Forming Biotransformations 5.1 Biocatalytic N-Acylation of Anilines in Aqueous Media</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">AD78F1FBE24932144B3A4922429DED44</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-24T12:30+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=0, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=true, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[0], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>The development of efficient and environmentally friendly methods for the synthesis of amides is of significance because they constitute the key functional group in a wide variety of biological and synthetic structures, including peptides, pharmaceuticals, polymers and pesticides [1]. Generally, the chemical synthesis of amides is performed in organic solvents and requires acyl halides and harsh conditions. To fulfil the increasing demand for green chemistry procedures (minimising the use of organic solvents), enzymes have been investigated for C-N bond formation activity in water [2]. The application of enzymes offers the advantages of high selectivity, mild reaction conditions and catalyst biodegradability. For instance, C-acyltransferase from Pseudomonas protegens has been identified not only as catalysing C-C bond formation in a Friedel-Crafts-type acylation [3] but also as exhibiting promiscuous N-acetylation activity, transforming aniline derivatives into the corresponding acetanilides (Scheme 5.1) [4].</p><p>Semipreparative transformations were performed starting with 0.25 mmol of substrate. Anilines were converted into the corresponding acetanilides using phenyl acetate as acetyl donor within 24 hr and the products were isolated by column chromatography with high yields. Whilst aniline derivatives bearing an OH group in the para-or ortho-position were not converted, meta-substituted hydroxyaniline led to 96% product yield 2a. Aniline, including anilines with various substituents in the para-position (Cl, i-Pr, Et), was well accepted, reaching yields up to 99%. Furthermore, anilines with an ethyl group in either the meta-or the ortho-position were accepted, with the para-substituted substrate reacting fastest (2e; 99%), followed by the meta-substituted one (2f; 98%) [4].</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="11" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="12" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="13" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="14" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="15" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="16" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="17" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="18" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="19" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="20" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="21" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="22" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="23" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="24" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="25" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="26" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="27" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="28" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="29" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="30" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="31" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="32" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="33" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="34" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="35" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="36" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="37" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="38" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="39" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="40" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="41" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="42" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="43" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
		<surface n="44" ulx="0.0" uly="0.0" lrx="481.89" lry="691.65"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><formula xml:id="formula_0">NH 2 R 1 R 2 NH O R 1 R 2 R 3</formula><p>PpATaseCH KPi-buffer pH 7.5 35 ¬∞C, 18 h co-product Ph O O PA Product 2a 2b 2c 2d 2e 2f 2g R 1 H H H H H H Et R 2 OH H H H H Et H R 3 H H Cl i-Pr Et H H Yield [%] 96 70 91 83 99 98 13 2a-2g 1a-1g 10 mM  2. Cell-free extract containing the PpATaseCH (2.5 mL, 1.65 U) was added to the reaction mixture and the bioacetylation was started by adding phenyl acetate (54.9 ŒºL, 15 mM final concentration). 3. The mixture was further diluted with KPi-buffer (100 mM, pH 7.5) to a total volume of 25 mL. 4. The bioacetylation was run at 35 ‚àò C and 140 rpm for 24 hr. 5. The resulting suspension was extracted with EtOAc (2 √ó 50 mL). The organic layers were pooled in a separation funnel, washed with brine (2 √ó 40 mL) and dried over anhydrous Na 2 SO 4 , and the solvent was removed under reduced pressure. 6. The crude product was purified by flash chromatography over silica gel using c-hexane/EtOAc as eluent (9 : 1 v/v). Fractions were collected and checked for the desired substances via TLC. c-Hexane/EtOAc (9 : 1 v/v) was used as TLC solvent and staining was performed with cerium or permanganate staining solution. Fractions containing the desired product were combined and evaporated.</p><p>N- <ref type="bibr">(3-hydroxyphenyl)</ref>acetamide was obtained as a white solid (29.1 mg) with 96% yield.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2">Enantioselective Enzymatic Hydroaminations for the Production of Functionalised Aspartic Acids</head><p>Haigen Fu, Jielin Zhang and Gerrit J. Poelarends * Department of Chemical and Pharmaceutical Biology, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands Optically pure functionalised aspartic acid derivatives are highly valuable as tools for biological research and as chiral building blocks for pharmaceuticals, nutraceuticals and agrochemicals <ref type="bibr">[1,</ref><ref type="bibr">4]</ref>. Despite their broad applications, the direct asymmetric synthesis of functionalised aspartic acids remains a challenge. Current chemical strategies for the synthesis of enantioenriched N-alkyl-substituted aspartic acids are mainly based on the aza-Michael addition of appropriate amines to maleic acid, fumaric acid or their derivatives (ester, amide or monoalkali salt) <ref type="bibr">[5,</ref><ref type="bibr">6]</ref>, followed by laborious purification and resolution to achieve the desired single enantiomer, and therefore lead to unsatisfactory product yields (&lt;50%). Biocatalysis provides a valuable alternative method for the production of chiral unnatural amino acids <ref type="bibr">[7,</ref><ref type="bibr">8]</ref>. We recently reported a biocatalytic route for the asymmetric synthesis of various N-(hetero)cycloalkyl-substituted L-aspartic acids using ethylenediamine-N,N'-disuccinic acid (EDDS) lyase as biocatalyst <ref type="bibr">[9]</ref>. EDDS lyase is a homotetrameric protein that belongs to the aspartase/fumarase superfamily and exploits a deamination mechanism involving general base-catalysed formation of a carbanion stabilised as its aci-carboxylate form <ref type="bibr">[10]</ref>. The enzyme naturally catalyses a reversible sequential two-step deamination of (S,S)-EDDS 1, converting 1 via the intermediate (S)-N-(2-aminoethyl)aspartic acid (AEAA) 3 into ethylenediamine 4 and two molecules of fumaric acid 2 (Scheme 5.2a) <ref type="bibr">[10]</ref>. In this section, we describe the expression and purification of the enzyme EDDS lyase, as well as its synthetic application in the enantioselective addition of heterocycloalkylamines 5a,b to fumaric acid 2 to produce N-heterocycloalkyl-substituted L-aspartic acid derivatives 6a,b (Scheme 5.2b).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.1">Procedure 1: Expression and purification of EDDS lyase</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.1.1">Materials and Equipment</head><p>‚Ä¢ Lysogenic broth (LB) agar plate with colonies of Escherichia coli TOP10 cells containing the pBADN (EDDS lyase-His) expression vector <ref type="bibr">[10]</ref> ‚Ä¢ Ampicillin (100 mg.mL -1 stock solution in water, filter-sterilised) ‚Ä¢ Arabinose (200 mg.mL -1 stock solution in water, filter-sterilised) ‚Ä¢ LB medium <ref type="bibr">(</ref> </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.1.2">Procedure</head><p>1. E. coli TOP10 cells containing the pBADN (EDDS lyase-His) plasmid were collected from an LB plate and used to inoculate sterile LB medium (10 mL), containing ampicillin (100 Œºg.mL -1 ), in a 50 mL conical-bottom centrifuge tube. 2. After overnight incubation at 37 ‚àò C and 200 rpm, the pre-culture was used to inoculate the rest of the LB medium (990 mL) containing ampicillin (100 Œºg.mL -1 ) in a 3 L Erlenmeyer flask. The cells were grown at 37 ‚àò C and 200 rpm for about 4 hr until OD 600 reached 0.8‚àº1.0. Then, arabinose (0.05% w/v) was added to induce enzyme expression.</p><p>Cultures were grown at 20 ‚àò C for 18 hr with shaking (200 rpm) on a rotary shaker. 3. The cells (4 g) were harvested by centrifugation (20 min at 6000√ó g and 4 ‚àò C). Cells harvested from 1 L of culture were resuspended in lysis buffer (15 mL, 50 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, pH 8.0). 4. Cells were disrupted by sonication for 4 √ó 40 sec (with a 5 min interval between each cycle) at a 60 W output. After centrifugation (45 min at 10 000√ó g and 4 ‚àò C), the soluble fraction (supernatant) containing EDDS lyase was separated from the insoluble part (pellet). 5. The supernatant was filtered through a pore filter (diameter 0.45 Œºm) and incubated with Ni sepharose 6 fast-flow resin (1 mL slurry in a filter cartridge used as column) at 4 ‚àò C for 18 hr, which had previously been equilibrated with lysis buffer. 6. The unbound proteins were eluted from the column by gravity flow. The column was washed first with lysis buffer (15 mL) and then with buffer A (30 mL, 50 mM Tris-HCl, 300 mM NaCl, 30 mM imidazole pH 8.0). Retained proteins were eluted with buffer B (5 mL, 50 mM Tris-HCl, 300 mM NaCl, 500 mM imidazole pH 8.0). Fractions were analysed by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on gels containing acrylamide (4-12%). 7. Fractions containing EDDS lyase were combined and loaded on to a HiLoad 16/600 Superdex 200 pg column, which had previously been equilibrated with buffer C (180 mL, 20 mM Na 2 HPO 4 , pH 8.5). The column was eluted with buffer C at 1 mL.min -1 for 1.2 column volumes. Fractions were collected and analysed by SDS-PAGE on gels containing acrylamide (4-12%).</p><p>8. The concentration of purified EDDS lyase in 20 mM Na 2 HPO 4 buffer (pH 8.5) was determined with a spectrophotometer using the method of Waddell <ref type="bibr">[11]</ref>. Around 60 mg (8.7 mg.mL -1 , 7 mL) of purified EDDS lyase was isolated from 1 L of cell culture following this protocol. The purified protein was divided into aliquots (200-500 ŒºL), frozen by liquid nitrogen and stored at -20 ‚àò C for further use.</p><p>5.2.2 Procedure 2: Synthesis of Compound 6a 5.2.2.1 Materials and equipment ‚Ä¢ 4-Aminopiperidine 5a (200 mg, 2 mmol; Sigma-Aldrich) ‚Ä¢ Fumaric acid 2 (0.2 mmol, 200 ŒºL of 1 M stock solution in 20 mM Na 2 HPO 4 buffer, pH 8.5) ‚Ä¢ EDDS lyase in 20 mM Na 2 HPO 4 buffer (8.7 mg.mL -1 , 2 mL, pH 8.5) ‚Ä¢ Na 2 HPO 4 buffer (20 mM, pH 8.5, 50 mL) ‚Ä¢ NH 3 aqueous solution (2 M, 200 mL) ‚Ä¢ HCl aqueous solution (1 M, 200 mL) ‚Ä¢ HCl aqueous solution (2 M, 200 mL) ‚Ä¢ NaOH solution (1 M, 200 mL) ‚Ä¢ CuSO 4 aqueous solution (0.5 mM, 1 L) ‚Ä¢ Ninhydrin solution in EtOH (1 g.L -1 , 100 mL) ‚Ä¢ Distilled water (1 L) ‚Ä¢ Balance ‚Ä¢ Standard pipettes ‚Ä¢ 50 mL measuring cylinder ‚Ä¢ 50√ó 15 mL test tubes ‚Ä¢ 50 mL round-bottom glass flask ‚Ä¢ 100 mL round-bottom glass flask ‚Ä¢ Dowex 50W X8 resin (hydrogen form, 100-200 mesh; Sigma-Aldrich) ‚Ä¢ Dowex 1X8 resin (chloride form, 100-200 mesh; Sigma-Aldrich) ‚Ä¢ TLC Silica Gel 60 F 254 aluminium plates (Merck) ‚Ä¢ Rotary evaporator connected to a vacuum pump ‚Ä¢ Electrospray ionisation orbitrap high-resolution mass spectrometer ‚Ä¢ pH meter ‚Ä¢ Nuclear magnetic resonance (NMR) tube ‚Ä¢ NMR spectrometer 5.2.2.2 Procedure 1. In a round-bottom glass flask (50 mL), 4-aminopiperidine 5a (200 mg, 2 mmol) and fumaric acid 2 (0.2 mmol, 200 ŒºL of 1 M stock solution) were added to 20 mM Na 2 HPO 4 buffer, pH 8.5 <ref type="bibr">(15 mL)</ref>. The pH of the initial mixture was adjusted to 8.5 with HCl solution (1 M). To start the reaction, 1.9 mL of EDDS lyase (16.5 mg, 8.7 mg.mL -1 , 3 √ó 10 -4 mmol, 0.15 mol% based on fumaric acid) was added, and the final volume of the reaction mixture was immediately adjusted to 20 mL with the same buffer. 2. The reaction mixture was incubated at room temperature for 7 days. After completion of the reaction, the enzyme was inactivated by heating to 70 ‚àò C for 10 min. The progress of the enzymatic reaction was monitored using 1 H NMR spectroscopy by comparing signals corresponding to fumaric acid (6.5 ppm) and amino acid product. 3. An anion-exchange resin column (10 g of Dowex 1X8 resin, 100-200 mesh) was prepared by pretreatment with a solution of aqueous HCl (2 M, 4 column volumes), aqueous NaOH (1 M, 2 column volumes) and distilled water (4 column volumes). A cation-exchange resin column (10 g of Dowex 50W X8, 100-200 mesh) was prepared by pretreatment with aqueous NH 3 (2 M, 4 column volumes), aqueous HCl (1 M, 2 column volumes) and distilled water (4 column volumes). 4. The precipitated enzyme was removed from the reaction mixture by filtration (pore diameter 0.45 Œºm) and the filtrate was loaded slowly on to the activated anion-exchange column (10 g of Dowex 1X8 resin, 100-200 mesh). The column was washed with distilled water to remove unbound amine (2 column volumes) and the product was eluted with aqueous HCl (2 M, 2 column volumes). 5. The ninhydrin-positive fractions were collected and loaded on to the activated cation-exchange column (10 g of Dowex 50W X8, 100-200 mesh). The column was washed with water (3 column volumes) to remove the remaining fumaric acid and eluted with 2 M aqueous ammonia until the desired product was collected. The ninhydrin-positive fractions were collected, concentrated under vacuum and lyophilised to provide the desired product. 6. The amino acid product 6a (91% conversion, 67% isolated yield, 29 mg, 1.3 √ó 10 -4 mol, white solid) was identified by 1 H NMR, 13 C NMR and high-resolution mass spectrometry (HRMS). 13 C NMR (126 MHz, D 2 O): ùõø 177.2, 173.5, 57.7, 51.9, 42.3 (2C), 36.2, 25.9, 25.4. HRMS (ESI + ): calcd for C 9 H 17 O 4 N 2 , 217.1183 [M+H]</p><p>+ , found, 217.1181. The enantiomeric excess (&gt;99% ee) was determined by chiral high-performance liquid chromatography (HPLC) analysis on a Nucleosil 5Œº chiral-1 120A (250 √ó 4.6 mm) column, using isocratic 0.5 mM CuSO 4 as mobile phase at a flow rate of 1 mL.min -1 , 60 ‚àò C, UV detected at 240 nm, t R = 6.4 min. ‚Ä¢ Distilled water (1 L) ‚Ä¢ Balance ‚Ä¢ Standard pipettes ‚Ä¢ 50 mL measuring cylinder ‚Ä¢ 50√ó 15 mL test tubes ‚Ä¢ 50 mL round-bottom glass flask ‚Ä¢ 100 mL round-bottom glass flask ‚Ä¢ Dowex 50W X8 resin (hydrogen form, 100-200 mesh; Sigma-Aldrich) ‚Ä¢ Dowex 1X8 resin (chloride form, 100-200 mesh; Sigma-Aldrich) ‚Ä¢ TLC Silica Gel 60 F 254 aluminium plates (Merck) ‚Ä¢ Rotary evaporator connected to a vacuum pump ‚Ä¢ Electrospray ionisation orbitrap high-resolution mass spectrometry ‚Ä¢ pH meter ‚Ä¢ NMR tube ‚Ä¢ NMR spectrometer 5.2.3.2 Procedure 1. In a 50 mL round-bottom glass flask, tetrahydro-2H-pyran-4-amine 5b (228 mg, 2 mmol) and fumaric acid 2 (0.2 mmol, 200 ŒºL of 1 M stock solution) were added to 20 mM Na 2 HPO 4 buffer, pH 8.5 (15 mL</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.3">Procedure 3: Synthesis of Compound 6b</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.3.1">Materials and Equipment</head><p>). The pH of the initial mixture was adjusted to 8.5 with a 1 M aqueous HCl solution. To start the reaction, 1.9 mL of EDDS lyase (16.5 mg, 8.7 mg.mL -1 , 3 √ó 10 -4 mmol, 0.15 mol% based on fumaric acid) was added, and the final volume of the reaction mixture was immediately adjusted to 20 mL with the same buffer. 2. The reaction mixture was incubated at room temperature for 7 days. After completion of the reaction, the enzyme was inactivated by heating to 70 ‚àò C for 10 min. The progress of the enzymatic reaction was monitored using 1 H NMR spectroscopy by comparing signals corresponding to fumaric acid (6.5 ppm) and amino acid product. 3. An anion-exchange resin column (10 g of Dowex 1X8 resin, 100-200 mesh) was prepared by pretreatment with a solution of aqueous HCl (2 M, 4 column volumes), aqueous NaOH (1 M, 2 column volumes) and distilled water (4 column volumes). A cation-exchange resin column (10 g of Dowex 50W X8, 100-200 mesh) was prepared by pretreatment with aqueous NH 3 (2 M, 4 column volumes), aqueous HCl (1 M, 2 column volumes) and distilled water (4 column volumes). 4. The precipitated enzyme was removed from the reaction mixture by filtration (pore diameter 0.45 Œºm) and the filtrate was loaded slowly on to the activated anion-exchange column (10 g of Dowex 1X8 resin, 100-200 mesh). The column was washed with distilled water to remove unbound amine (2 column volumes) and the product was eluted with aqueous HCl (2 M, 2 column volumes). 5. The ninhydrin-positive fractions were collected and loaded on to the activated cation-exchange column (10 g of Dowex 50W X8, 100-200 mesh). The column was washed with water (3 column volumes) to remove the remaining fumaric acid and eluted with 2 M aqueous ammonia until the desired product was collected. The ninhydrin-positive fractions were collected, concentrated under vacuum and lyophilised to provide the desired product.</p><p>6. The amino acid product 6b (84% conversion, 41% isolated yield, 18 mg, 8.3 √ó 10 -5 mol, white solid) was identified by 1 H NMR, 13 C NMR, and HRMS.</p><p>1 H NMR (500 MHz, D 2 O): ùõø 4.07-4.03 (m, 2H), 3.98 (dd, J = 9.0, 3.8 Hz, 1H), 3.53-3.45 (m, 3H), 2.85 (dd, J = 17.6, 3.8 Hz, 1H), 2.71 (dd, J = 17.7, 9.0 Hz, 1H), 2.12-2.04 (m, 2H), 1.82-1.70 (m, 2H); 13 C NMR (126 MHz, D 2 O): ùõø 177.3, 173.8, 65.7 (2C), 57.1, 53.4, 36.3, 29.5, 29.0. HRMS (ESI + ): calcd for C 9 H 16 O 5 N, 218.1023 [M+H]</p><p>+ , found, 218.1023. The enantiomeric excess (&gt;99% ee) was determined by chiral HPLC analysis on a Nucleosil 5Œº chiral-1 120A (250 √ó 4.6 mm) column, using isocratic 0.5 mM CuSO 4 as mobile phase at a flow rate of 1 mL.min -1 , 60 ‚àò C, UV detected at 240 nm, t R = 6.7 min.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.4">Analytical Method</head><p>The biocatalytic conversions of fumaric acid 2 into products 6a,b were monitored using 1 H NMR spectroscopy. At regular time intervals (typically 24 hr), a sample (300 ŒºL) was taken from the reaction mixture and heated at 70 ‚àò C for 10 min. The sample was then filtered through a pore filter (diameter 0.45 Œºm) and the filtrate was evaporated under vacuum. The resulting residue was dissolved in 0.5 mL of D 2 O for 1 H NMR measurement. The conversion was estimated by comparing the signals of fumaric acid (6.5 ppm) and corresponding product in 1 H NMR spectra. The workup procedure was initiated when the fumaric acid (6.5 ppm) signal had almost vanished, indicating high conversion of the fumaric acid 2.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.2.5">Conclusion</head><p>The enzyme EDDS lyase can be readily produced and purified, with about 60 mg being obtained from 1 L of cell culture. After initial freezing in liquid nitrogen, the enzyme can be stored at -20 ‚àò C in a concentration of 8.7 mg.mL -1 (in 20 mM Na 2 HPO 4 buffer, pH 8.5) for at least 6 months without significant loss of catalytic activity. We have showcased how EDDS lyase can accept the non-natural amine substrates 5a,b in the enantioselective hydroamination of fumarate, yielding the corresponding N-heterocycloalkyl-substituted L-aspartic acids 6a,b with high conversions (84-91%), good isolated yields (41-67%) and excellent stereoselectivity (&gt;99% ee) (Table <ref type="table" target="#tab_7">5</ref>.1).</p><p>In addition, we previously reported that EDDS lyase can accept a panel of homo-and heterocycloalkyl amines (comprising four-, five-and six-membered rings) in the selective addition to fumarate, giving the corresponding N-(hetero)cycloalkyl-substituted L-aspartic acids with excellent optical purity (&gt;99% ee in all cases) <ref type="bibr">[9]</ref>. Except for the broad cycloalkylamines scope, we recently demonstrated that EDDS lyase can also accept a wide variety of structurally distinct amines for stereoselective addition to fumarate, providing (chemo)enzymatic access to various aminocarboxylic acids, including the natural product toxin A and aspergillomarasmine A <ref type="bibr">[12]</ref>, difficult-to-synthesise N-arylated aspartic acid derivatives <ref type="bibr">[13]</ref> and substituted pyrazolidin-3-ones <ref type="bibr">[13]</ref>. As such, EDDS lyase, with its remarkably broad amine scope, nicely complements the biocatalytic toolbox for the synthesis of noncanonical amino acids.  d The ee values were determined by chiral HPLC analysis using chemically synthesised reference compounds with known configuration.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3">Biocatalytic Asymmetric Aza-Michael Addition Reactions and Synthesis of L-Argininosuccinate by Argininosuccinate Lyase ARG4-Catalysed Aza-Michael Addition of L-Arginine to Fumarate</head><p>Bernhard Schoenenberger, 1 Agata Wszolek, 2 Roland Meier, 1 Henrike Brundiek, 2  Markus Obkircher 1 and Roland Wohlgemuth</p><p>1 1 Sigma-Aldrich/Merck KGaA, Buchs,Switzerland 2 Enzymicals, Greifswald, Germany 3 Institute of Technical Biochemistry, Technical University Lodz, Lodz,Poland</p><p>Enzymes catalysing addition reactions of nucleophiles to conjugated acceptor systems are of great interest for generating complexity by enabling the formation of new bonds to carbon from simple building blocks. The formation of new carbon-carbon bonds by biocatalytic Michael addition reactions has been demonstrated in both natural metabolic pathways <ref type="bibr">[1,</ref><ref type="bibr">2]</ref> and the biocatalytic synthesis of more complex target compounds <ref type="bibr">[3,</ref><ref type="bibr">4]</ref>. Lipase B from Pseudozyma antarctica has been investigated for the catalysis of carbon-carbon <ref type="bibr">[5]</ref> bond-forming Michael addition reactions, whereby a Ser 105 Ala mutant favoured the Michael addition reaction 100 times and at the same time suppressed the hydrolysis reaction more than 1000 times. Biocatalysts are also of much interest for the construction of new carbon-nitrogen bonds by the addition of nitrogen nucleophiles to Œ±,Œ≤-unsaturated carbonyl compounds in aza-Michael addition reactions, which can be considered hydroaminations of Œ±,Œ≤-unsaturated carbonyl compounds. Aza-Michael addition reactions represent an important and well-studied class of reactions in synthetic organic chemistry, which offer great opportunities for new resource-efficient and sustainable chemistry, especially in cases where lengthy synthetic routes can be replaced by one step, protection-group free routes with high atom economy using highly enantioselective catalysts to avoid tedious purification of stereoisomer mixtures. Various lipases have been demonstrated to catalyse carbon-nitrogen bond-forming Michael addition reactions of various primary and secondary amines with a series of unsubstituted and substituted acrylic acid esters <ref type="bibr">[6,</ref><ref type="bibr">7]</ref>, as illustrated by the generalised reaction at the top of Scheme 5.3. High chemoselectivity and good yields were achieved in lipase-catalysed aza-Michael addition reactions by careful choice of the lipase and the reaction conditions; however, in the case of the substituted acrylic acid esters, enantioselectivity was not reported <ref type="bibr">[6]</ref>. As the catalytic asymmetric aza-Michael addition is an attractive reaction for the construction of new chiral centres and enzymes are inherently chiral catalysts by nature, it is worthwhile to search for enzymes capable of catalysing the direction of synthesis or degradation. Enzymes from EC class 4.3, the C-N-lyases, known to catalyse the cleavage of carbon-nitrogen bonds, can also be utilised to catalyse the formation of carbon-nitrogen bonds in the reverse direction. Such C-N Lyases are therefore excellent catalysts for enabling the highly regio-and stereoselective addition of nucleophiles containing terminal amino groups to conjugated carbon-carbon double bonds, as demonstrated recently by a number of examples from a great variety of aminocarboxylic acids <ref type="bibr">[8,</ref><ref type="bibr">12]</ref>. A selection of preparative applications of biocatalytic aza-Michael addition reactions using lipases and ethylenediamine-N,N ‚Ä≤ -disuccinic acid lyase (EDDS lyase) are illustrated in Scheme 5.3.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>N N-(([(4S)-4-Amino-4-carboxy-butyl]amino) iminomethyl)-L-aspartic acid</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Scheme 5.4 Argininosuccinate lyase ARG4-catalysed aza-Michael addition of L-arginine to fumarate.</head><p>Argininosuccinate lyase EC 4.3.2.1, a C-N lyase highly conserved in bacteria and eukaryotes, is also able to catalyse the reverse reaction, the aza-Michael addition of L-arginine to fumarate to form the amino acid N-(([(4S)-4-amino-4-carboxybutyl]amino)iminomethyl)-Laspartate; in short, L-argininosuccinate (Scheme 5.4), a nonproteinogenic natural amino acid and a key metabolite of the urea cycle and L-arginine metabolism. The synthesis of pure L-argininosuccinate has been achieved using recombinant argininosuccinate lyase ARG as catalyst for the synthesis of L-argininosuccinate in the lithium salt form at preparative scale.</p><p>The synthetic route in Scheme 5.4 is the reverse direction of the urea cycle in healthy humans, where the argininosuccinate lyase catalyses the cleavage reaction of the L-argininosuccinate, which is formed by the argininosuccinate synthase-catalysed condensation of aspartate and citrulline.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.1">Procedure 1: Recombinant Expression of ARG4 in E. coli BL21(DE3)</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.1.1">Materials and Equipment</head><p>‚Ä¢ Escherichia coli BL21(DE3) cells ‚Ä¢ Lysogenic broth (LB) plates (15 g.L -1 agar, 10 g.L -1 tryptone, 10 g.L -1 NaCl, 5 g.L -1 yeast extract, pH 7.5) with 50 Œºg.mL -1 kanamycin</p><p>‚Ä¢ LB medium (10 g.L -1 tryptone, 10 g.L -1 NaCl, 5 g.L -1 yeast extract, pH 7.5) with 50 Œºg.mL -1 kanamycin ‚Ä¢ Terrific broth (TB) medium (12 g.L -1 casein, enzymatically digested, 24 g.L -1 yeast extract, 12.54 g.L -1 K 2 HPO 4 , 2.31 g.L -1 KH 2 PO 4 , pH 7.5) with 50 Œºg.mL (strain ATCC 204508/S288c) (UniProtKB: P04076). The synthetic gene was codon optimised for E. coli and equipped with an N-terminal 6x-his-tag and a TEV protease cleavage site for optional removal of the affinity tag. The gene was synthesised and subcloned into pET24a(+) via NdeI and NotI by Genscript, giving vector pET24-His(TV)-ARG4-E. coli(op). 2. Chemically competent BL21 (DE3) E. coli cells (100 ŒºL; 100 ŒºL aliquots were stored at -80 ‚àò C until usage) were transformed with 5 ŒºL of the derived plasmid by using standard procedures <ref type="bibr">[13]</ref> and plated on LB agar supplemented with 50 Œºg.mL -1 kanamycin for selection. Selected E. coli transformants were used for expression tests, in which different media, induction times and temperatures were optimised. The selected conditions were later used for the overexpression of ARG4 in E. coli BL21 (DE3), as shown in the following steps. 3. A single E. coli colony harbouring ARG4 gene was inoculated into 5 mL LB medium supplemented with kanamycin (50 Œºg.mL -1 ) and incubated overnight at 30 ‚àò C and 180 rpm. 4. Overnight cultures of E. coli were used to inoculate 50 mL of TB medium supplemented with kanamycin (50 Œºg.mL -1 ) in 250 mL baffled flasks. Cells were cultivated at 37 ‚àò C under vigorous shaking (150 rpm) until an OD 600 of 0.5 was reached. 5. When the pre-culture reached the mid-log phase as follows, the main culture was started. Fresh TB medium (400 mL) in a 2 L Erlenmeyer flask was inoculated with the E. coli pre-culture (20 mL). Cells were cultivated at 37 ‚àò C under shaking (110 rpm) until an OD 600 of 1.3 was reached. 6. After the culture reached OD 600 1.3, protein expression was induced with IPTG to a final concentration of 1mM and the incubation temperature was shifted to 25 ‚àò C and the main culture shaken at 110 rpm for 20 hr. Cells were harvested by centrifugation at 5000 rpm and 4 ‚àò C for 30 min and washed once with 40 mL of ice-cold 50 mM sodium phosphate buffer at pH 7.5. The E. coli cell pellets containing the overexpressed enzyme (recombinant ARG4) were frozen at -20 ‚àò C. 7. For cell disruption, frozen cells were adjusted to OD 600 40 in 50 mM potassium phosphate buffer pH 7.5 and mixed with glass beads (√ò 0.25-0.5 mm) at an approximate ratio of 1 : 1. The cells were disintegrated mechanically by a cell disruptor (Retsch Mixer Mill MM 200: two cycles for 5 min at 600 rpm). 8. The samples were cooled on ice and insoluble cell debris was removed by centrifugation (5000 rpm, 4 ‚àò C, 30 min). 9. The supernatant containing the soluble protein fraction was purified by incubating the soluble protein fraction with Talon ¬Æ resin on an orbital shaker (30 min, 4 ‚àò C). 10. A standard gravity flow protocol was applied to purify the ARG4 target protein. Therefore, the resin was washed at 4 ‚àò C with 10 column volumes of 50 mM potassium phosphate buffer pH 7.5 containing 10 mM imidazole to remove unspecifically bound protein and the target protein ARG4 was eluted with 1.5 column volumes of elution buffer (50 mM potassium phosphate buffer pH 7.5, 150 mM imidazole). 11. Purified ARG4 was obtained by removing imidazole on desalting columns using 50 mM potassium phosphate buffer pH 7.5 with Zeba Spin columns.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.2">Procedure 2: ARG4-Catalysed Asymmetric Michael Addition Reaction of L-Arginine to Fumarate</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.2.1">Materials and Equipment</head><p>‚Ä¢ L-Arginine (870 mg, 5 mmol)</p><p>‚Ä¢ Fumaric acid (580 mg, 5 mmol) ‚Ä¢ H 2 O (100 mL) ‚Ä¢ 1 M aqueous LiOH ‚Ä¢ Soluble fraction of the purified cell extract of E. coli overexpressing recombinant argininosuccinate lyase (ARG4; 500 ŒºL). ‚Ä¢ Round-bottom flask ‚Ä¢ n-Propanol ‚Ä¢ Flash chromatography equipment ‚Ä¢ Silica for flash chromatography ‚Ä¢ Rotary evaporator with high vacuum ‚Ä¢ Filter equipment ‚Ä¢ Lyophiliser ‚Ä¢ Silica thin-layer chromatography (TLC) plates ‚Ä¢ UV cabinet consisting of UV lamp 254 nm and viewing box ‚Ä¢ Ninhydrin ‚Ä¢ Nuclear magnetic resonance (NMR) spectrometer 1 H 600 MHz 5.3.2.2 Procedure 1. A mixture of L-arginine (870 mg, 5 mmol) and fumaric acid (580 mg, 5 mmol) in H 2 O</p><p>(100 mL) was adjusted to pH 7.5 with 1 M aqueous LiOH. To this solution was added the soluble fraction of the purified cell extract of E. coli overexpressing recombinant argininosuccinate lyase (ARG4; 500 ŒºL). 2. The solution was stirred at room temperature and the progress of the reaction was monitored periodically by 1 H-NMR and TLC. 3. After the conversion ceased (6 days), the mixture was concentrated by standard rotary evaporation under reduced pressure using membrane pumps and then dried at the even further reduced pressure of 0.1-0.01 mbar and room temperature, giving a white solid. This was dissolved in H 2 O (5 mL), and then n-propanol (10 mL) was added. 4. The resulting emulsion was flash-chromatographed on silica with n-propanol/H 2 O 2 : 1.</p><p>The early fractions contained unreacted fumarate, followed by the L-argininosuccinate in later fractions. 5. Fractions containing the product, which eluted from the silica column as the lithium salt of L-argininosuccinate, were pooled, filtered, frozen and lyophilised to give 1.07 g (‚àº70%) of the pure product N-(([(4S)-4-amino-4-carboxy-butyl]amino)-iminomethyl)-L-aspartic acid lithium salt (L-argininosuccinic acid lithium salt) in the form of a colourless solid.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>N-(([(4S)-4-amino-4-carboxy-butyl]amino</head><p>) imino-methyl)-L-aspartic acid lithium salt (L-argininosuccinic acid mono-lithium salt) NMR: ùõø H (400 MHz; D 2 O) 4.14 (1H, dd, J1 = 3.4, J2 = 9.9, succinyl-CH-NH), 3.65 (1H, dd, J1 = J2 = 6.2, arginyl-CŒ±H), 3.17 (2H, t, J = 6.8, arginyl-CùõøH2), 2.71 (1H, dd, J1 = 3.4, J2 = 16.1, succinyl-CH), 2.41 (1H, dd, J1 = 9.9, J2 = 16.</p><p>1, succinyl-CH¬¥), 1.80 (2H, m, arginyl-CbH2), 1.58 (2H, m, arginyl-CgH2); dC (100.6 MHz; D2O) 178.9, 177.1, 174.4 (3 COOH), 155.8 (guanidino-C), 55.1, 54.3 (2 NH2-C-COOH), 40.6 (succinyl-CH2 and arginyl-Cd), 27.6 (arginyl-Cb), 23.9 (arginyl-Cg). H2O content (Karl Fischer titration): 14.1% elemental analysis, found: C, 33.3; H, 6.2; N, 15.5%. Calculated for C 10 H 16 N 4 O 6 Li 2 . 14.1% H2O: C, 35.2; H, 6.2; N 16.4%; quantitative NMR (qNMR), content: 94.4% (calculated as di-lithium salt including 14.1% H 2 O).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.3">Analytical Method</head><p>The protein content of the purified protein was determined with the bicinchoninic acid assay (BCA) method using bovine serum albumin (BSA) as a standard. The analysis of ARG4 overexpression and purity was performed using 12.5% SDS-polyacrylamide gels. The gels were stained with Coomassie Blue.</p><p>Argininosuccinate lyase ARG4 activity was assayed at 25 ‚àò C spectrophotometrically by the absorbance change at 240 nm due to the formation of fumarate during the reaction (Œµ = 2.44 √ó 10 3 M -1 .cm -1 ). The assay mixture contained 50 mM potassium phosphate buffer pH 7.5 and 1 mM of potassium L-argininosuccinate in a total volume of 1 mL and the reaction was initiated by the addition of the recombinant protein.</p><p>The TLC analysis was done with silica plates using n-propanol/H 2 O 2 : 1 as solvent, detection by ninhydrin and exposition to short-wave UV light at 254 nm. Under these TLC conditions, the Rf of fumaric acid was 0.7 and that of arginine was 0.1. The final product, which was analysed with plate silica gel K60, mobile phase n-propanol/H 2 O 2 : 1, detected with ninhydrin and scanned with CAMAG Linomat 5, showed a purity of 95.1% by this special TLC method.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.4">Conclusion</head><p>A simple and straightforward biocatalytic asymmetric aza-Michael addition reaction has been established for the synthesis of the key metabolite N-(([(4S)-4-amino-4-carboxybutyl] amino) imino methyl)-L-aspartic acid, commonly referred to as L-argininosuccinate. This one-step addition reaction was developed by running part of the urea cycle in reverse. Argininosuccinate lyase from S. cerevisiae was selected as biocatalyst. The corresponding gene ARG4 was expressed in E. coli for the production of the highly active and stable argininosuccinate lyase biocatalyst. The use of this argininosuccinate lyase and reaction monitoring by NMR enabled the development of a biocatalytic asymmetric aza-Michael addition reaction as a novel green chemistry route with high molecular economy for the synthesis of this important metabolite at gram scale.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.3.5">Acknowledgement</head><p>Reproduced from Ref. <ref type="bibr">[9]</ref> with permission from the Royal Society of Chemistry.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.4">Convenient Approach to the</head><p>Biosynthesis of C2,C6-Disubstituted Purine Nucleosides Using E. coli Purine Nucleoside Phosphorylase and Arsenolysis Irina D. Konstantinova * , Alexey L. Kayushin, Alexandra O. Arnautova, Konstantin V. Antonov, Barbara Z. Yeletskaya, Mariya Ya. Berzina, Elena V. Dorofeeva, Olga I. Lutonina, Ilya V. Fateev, Roman S. Esipov and Anatoly I. Miroshnikov Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russian Federation</p><p>In recent years, the transglycosylation reaction catalysed by Escherichia coli nucleoside phosphorylases has been widely used in the synthesis of modified nucleosides <ref type="bibr">[1]</ref>.</p><p>During this reaction, a carbohydrate residue is transferred to a modified base (substituted purines <ref type="bibr">[2]</ref>, benzimidazoles <ref type="bibr">[3]</ref> or 1,2,4-triazole-3-carboxamides <ref type="bibr">[4]</ref>). The base can be used as is or as part of a riboside. Often, the use of this reaction is constrained by the need to shift the equilibrium towards the desired product. This is usually achieved by introducing into the reaction mixture an excess of one of the starting components or by selective removal of the poorly soluble target nucleosides (e.g. in case of Fludarabine) from the reaction medium <ref type="bibr">[5]</ref>. However, even under those conditions, the maximum possible conversion of the starting nucleosides into target compounds is not higher than 50-60%. We found that the use of salts of ortho-arsenic acid during the transglycosylation reaction shifts the equilibrium towards the formation of the target arabinonucleosides <ref type="bibr">[6]</ref>. The arsenolysis reaction can be expanded to obtain purine 3'-deoxyribosides. The shift of equilibrium towards the target product occurs due to the removal of ribose from the reaction: ribose arsenate obtained in the active centre of the enzyme is extremely unstable in solutions and decomposes, forming ribose and arsenate (Scheme 5.5). As a result, the equilibrium shifts towards the formation of the target nucleosides with conversion of 80-95%. Arsenate can be added both at the start of the reaction and after establishment of equilibrium. ‚Ä¢ High-performance liquid chromatography (HPLC) system (Waters Breeze, column Nova-Pack C 18 , 4.6 √ó 150 mm, 4 Œºm) ‚Ä¢ Flash column (30 √ó 170 mm, Separon CGX C 18 , 60 Œºm, Tessek Ltd) ‚Ä¢ Rotary evaporator (B√ºchi) 5.4.1.2 Procedure 1. 3'-dI (100 mg, 0.38 mmol), 6-O-methylguanosine (50 mg, 0.17 mmol) and KH 2 PO 4 (27.4 mg, 2 mmol) were dissolved in H 2 O (170 mL) in a 0.25 L Schott bottle with screw cap. pH was adjusted to 7.0 with 3 M KOH (aqueous). 2. PNPase E. coli (1230 units) was added to the reaction mixture. The reaction was incubated at 50 ‚àò C. Progress was monitored by HPLC. Samples (5 ŒºL) were analysed by HPLC System Waters Breeze with a Nova-Pack column (see Table 5.2 for the HPLC data). 3. (a) After achieving 76-78% conversion of 6-O-methylguanosine into 6-O-Me-Gua-3'-dR (7 days, determined by HPLC), Na 2 HAsO 4 solution (1 mM, 10 mL) was added to the reaction mixture. In 1.5 hr, 98-99% conversion of starting 6-O-methylguanosine was achieved (HPLC data). (b) Arsenate can be added (1 mM, 2 mL) just after addition of PNPase E. coli. In this case, 98-99% conversion is achieved in 3 days. The reaction mixture was cooled to room temperature, EtOH (60 mL) was added and the solution was concentrated to ‚àº10 mL by distillation under reduced pressure. 4. The target product was isolated by chromatography on Separon CGX C 18 (elution by gradient of MeOH in H 2 O, 0-70%, 500 mL, flow rate 6.8 mL.min -1 ). Fractions containing the desired product (identified by HPLC) were combined, concentrated by distillation under reduced pressure and lyophilised. Yield was 35 mg (0.12 mmol, 71%). Purity was 99% (HPLC data). UV: (H 2 O, pH 7.0) ùúÜ max , nm (Œµ, M -1 .cm -1 ): 279 (8320); ùúÜ min , nm: 226 (7853). HRMS (ESI + ), m/z [M+H] + : calculated for C 11 H 17 N 5 O 4 282.11856, found 282.11876; [base+H] + : calculated for C 6 H 9 N 5 O 166.07293, found 166.07274; [2M+Na] + : calculated for C 22 H 34 N 10 NaO 8 585.21078, found 585.21034.   </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.4.2">Conclusion</head><p>The described procedure allows the regio-and stereoselective production of the 3'-deoxyriboside-6-methoxyguanosine in high yield using standard chemical and microbiological laboratory equipment and methods. In principle, this procedure can be adapted for related substrates by the choice of suitable enzymes.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.5">Production of L-and D-Phenylalanine Analogues Using Tailored</head><p>Phenylalanine Ammonia-Lyases Emma Z.A. Nagy, 1 Souad D. Tork, 1 Alina Filip, 1 L√°szl√≥ Poppe,</p><p>1,2 Monica I. To≈üa, 1 Csaba Paizs 1 and L√°szl√≥ C. Bencze *1 1 Biocatalysis and Biotransformation Research Center, Faculty of Chemistry and Chemical Engineering, Babe≈ü-Bolyai University, Cluj-Napoca, Romania 2 Department of Organic Chemistry and Technology, Budapest University of Technology and Economics, Budapest, Hungary</p><p>The biocatalytic synthesis of optically pure L-and D-unnatural phenylalanines with high synthetic value is continuously providing new green synthetic procedures. Recently, by mapping the binding pocket of phenylalanine ammonia-lyase from Petroselinum crispum (PcPAL), we developed tailored variants to use as biocatalysts for the synthesis of several phenylalanine analogues <ref type="bibr">[1]</ref><ref type="bibr">[2]</ref><ref type="bibr">[3]</ref>. L-p-Br-phenylalanine L-1b is an important intermediate for the production of several valuable biarylalanines <ref type="bibr">[4]</ref>, whilst D-p-CH 3 -phenylalanine D-1a has been successfully incorporated into Pin1 inhibitors <ref type="bibr">[5]</ref> and into anti-inflammatory formyl-peptide receptor 1 antagonists <ref type="bibr">[6]</ref>. The efficient PcPAL-mediated synthesis of these products can be achieved by performing the corresponding ammonia elimination and ammonia addition reactions (Scheme 5.6) using Escherichia coli Rosetta cells, harbouring the plasmid carrying the gene of the tailored PcPAL I460V variant, as whole-cell biocatalysts.</p><p>Within the kinetic resolution-type ammonia elimination reaction, the substrate is the racemic p-CH 3 -phenylalanine rac-1a, from which the L-enantiomer L-1a is dehydroaminated to p-CH 3 -cinnamic acid 2a, yielding the unreacted D-p-CH 3 -phenylalanine D-1a in a maximal theoretical yield of 50%. Meanwhile, the asymmetric synthetic route of the ammonia addition reaction, using p-Br-cinnamic acid 2b as substrate, provides L-p-Br-phenylalanine L-1b in 100% theoretical yield. 5.5.1 Procedure 1: Preparation of Whole-Cell Biocatalysts for Enzymatic Reactions 5.5.1.1 Materials and Equipment </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.5.2.1.2">Ammonia Addition Reaction.</head><p>‚Ä¢ Aqueous NH 4 OH (220 mL, 6 M, pH 9.5, adjusted with CO 2 in dH 2 O; buffer solution for ammonia addition reaction) ‚Ä¢ p-Bromo-cinnamic acid (500 mg, 2.2 mmol) ‚Ä¢ Whole-cell pellet (the amount resuspended in the reaction buffer provides a cell density of OD 600 ‚àº10; see Procedure 1 for the calculation of the volume of bacterial culture providing the required whole-cell pellet) ‚Ä¢ 0. </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.5.3">Procedure 3: Monitoring the Biotransformations and Isolation of Products</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.5.3.1">Materials and Equipment</head><p>‚Ä¢ Aqueous H 2 SO 4 (10%)</p><p>‚Ä¢ Ethyl acetate ‚Ä¢ NH 4 OH (2 M aqueous) ‚Ä¢ Na 2 SO 4 , anhydrous ‚Ä¢ Distilled water (dH 2 O) ‚Ä¢ Dowex ¬Æ 50WX2 resin (15 mL in 10% H 2 SO 4 ) ‚Ä¢ pH paper ‚Ä¢ Erlenmeyer flasks ‚Ä¢ Rotatory evaporator (Heidolph Hei-VAP Ultimate) ‚Ä¢ Cooling centrifuge (Thermo Scientific SL 16R) ‚Ä¢ 50 mL centrifuge tubes PP with screw cap PE ‚Ä¢ Separatory funnel (500 mL)  </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.5.3.2">Procedure</head><p>1. The conversions of the preparative-scale enzymatic reactions were determined using the HPLC methods presented in Table <ref type="table" target="#tab_7">5</ref>.3. 2. When the enzymatic reactions reached the stationary conversions (after ‚àº30 hr at c = 49% in the case of rac-p-CH 3 -phenylalanine, and after ‚àº48 hr at c = 86% in the case of p-Br-cinnamic acid), the reaction mixture was acidified to pH 1.5 by dropwise addition of aqueous H 2 SO 4 (10%, 50% w/v). The pH of the mixture was verified using pH paper. 3. The precipitate and cell debris were removed by centrifugation of the acidified reaction mixture in 50 mL polypropylene centrifuge tubes with polyethylene screw caps at 10 000 rpm (10 947√ó g), 4 ‚àò C for 20 min. 4. After discarding the precipitate, the produced or remaining cinnamic acid (p-CH 3 -cinnamic acid 2a or p-Br-cinnamic acid 2b, correspondingly) was recovered by extracting the reaction mixture with ethyl acetate (3 √ó 40 mL) using a separatory funnel (500 mL). After drying of the organic phase with anhydrous Na 2 SO 4 and concentration by distillation under reduced pressure, the cinnamic acid (2a or 2b) was recovered. 5. The amino acid (D-1a or L-1b) found within the extracted aqueous phase was purified by ion-exchange chromatography using Dowex ¬Æ 50WX2 resin (15 mL in 10% H 2 SO 4 ). First, Dowex ¬Æ 50WX2 resin (15 mL) was activated by washing the resin with 10% H 2 SO 4 (100 mL), and then the extracted aqueous phase was loaded. 6. The column was washed with H 2 SO 4 (10% -3 √ó 10 mL), then with distilled water (dH 2 O), until pH of 6-7 was reached (monitored by pH paper) 7. For the elution of the amino acid (D-1a or L-1b), 100 mL 2 M NH 4 OH solution was used. 8. The column was further washed with distilled water (dH 2 O) until a pH of 6-7 was again established. 9. The resin was washed with 10% H 2 SO 4 (50 mL) and stored in 10% H 2 SO 4 for further use. 10. The fraction eluted with the 2 M NH 4 OH solution was concentrated by distillation under reduced pressure, affording the pure amino acid (D-1a or L-1b).  11. The purity of the isolated products and their enantiomeric excess (ee) values (Table <ref type="table" target="#tab_7">5</ref>.5) were assessed by HPLC, using the methods from Tables 5.3 and 5.4.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.5.4">Conclusion</head><p>We have described some highly efficient biocatalytic procedures for the synthesis of valuable enantiopure L-and D-phenylalanine analogues, such as L-p-Br-phenylalanine and D-p-CH 3 -phenylalanine, using as biocatalyst recombinant E. coli whole cells harbouring the PcPAL I460V variant. The procedure can be applied for the synthesis of several other optically pure phenylalanine derivatives using the corresponding tailored PcPAL mutants [1, 2].</p><p>5. Dong, L., Marakovits, J., Hou, X. et al. (2010) Bioorganic &amp; Medicinal Chemistry Letters, 20, 2210-2214. 6. Hwang, T.L., Hung, C.H., Hsu, C.Y. et al. (2013) Organic and Biomolecular Chemistry, 11, 3742-3755. 7. Dima, N.A., Filip, A., Bencze, L.C. et al. (2016) Studia Universitatis Babe≈ü-Bolyai Chemia, 61</p><p>, 21-34.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.6">Asymmetric Reductive Amination of Ketones Catalysed by Amine Dehydrogenases</head><p>Vasilis Tseliou, 1 Wesley B√∂hmer, 1 Maria L. Corrado, 1 Marcelo F. Masman, 1 Tanja Knaus 1 and Francesco G. Mutti *1 1 Van 't Hoff Institute for Molecular Sciences, HIMS-Biocat, University of Amsterdam, Amsterdam, The Netherlands Amine dehydrogenases (AmDHs) are NADH/NADPH-dependent enzymes that catalyse the reversible conversion of ketones and aldehydes into enantiomerically pure amines at the sole expense of ammonia and a hydride source. The latter is required for co-factor recycling and can usually be formate or glucose <ref type="bibr">[1,</ref><ref type="bibr">2]</ref>. A second enzyme such as a formate dehydrogenase (FDH) or a glucose dehydrogenase (GDH) catalyses the co-factor recycling. The AmDH-FDH (or GDH) system offers elevated atom economy, as the buffer of the reaction (HCOONH 4 ) directly provides the source of nitrogen and the reducing equivalents. Thus, only a catalytic amount of NAD(P)H is needed, whilst carbonate and water are the byproducts (Scheme 5.7). There are currently 14 AmDH family members. They have either been created by enzyme engineering starting from L-amino acid dehydrogenases (L-AADHs) <ref type="bibr">[2]</ref> or been discovered as native (nat-AmDHs) using metagenomic data <ref type="bibr">[3]</ref>. The substrate scope of these AmDHs already covers a significant range of structurally diverse carbonyl compounds, giving access to approximately 80 Œ±-chiral amines in high optical purity. This section describes the detailed procedure for the preparation and application of four engineered AmDHs: (i) Bb-PhAmDH, engineered from Bacillus badius phenylalanine dehydrogenase <ref type="bibr">[4,</ref><ref type="bibr">5]</ref>; (ii) cFL1-AmDH, a chimera obtained by domain shuffling from two first-generation AmDH variants <ref type="bibr">[5,</ref><ref type="bibr">6]</ref>; (iii) Rs-PhAmDH, engineered from Rhodococcus sp. M4 phenylalanine dehydrogenase <ref type="bibr">[5,</ref><ref type="bibr">7]</ref>; and (iv) LE-AmDH-v1, engineered from Geobacillus sterothemophilus Œµ-deaminating L-lysine dehydrogenase <ref type="bibr">[8]</ref>. The enzymes</p><formula xml:id="formula_2">NADH/H + NAD + Cb-FDH HCO 3 - HCOO - NH 3 H 2 O AmDHs R 1 R 2 O R 1 * R 2 NH 2</formula><p>Scheme 5.7 Biocatalytic amination using AmDHs with co-factor recycling.</p><p>can be applied in tandem with FDH from Candida boidinii <ref type="bibr">[9]</ref> for the reductive amination of carbonyl compounds. Overall, these AmDHs can give access to R-configured amines, as shown in Table <ref type="table" target="#tab_7">5</ref>.6.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.6.1">Procedure 1: Expression of the Catalysts</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.6.1.1">Materials and Equipment</head><p>‚Ä¢ Sterilised lysogenic broth (LB) medium (330 mL; 10 g.L -1 tryptone (Oxoid LP0042), 5 g.L -1 yeast (Oxoid LP0021), 5 g.L -1 NaCl) ‚Ä¢ Kanamycin (stock solution, 50 mg.mL -1 ) ‚Ä¢ Escherichia coli cells harbouring the plasmids coding for the AmDHs (Bb-PhAmDH, Rs-PhAmDH, cFL1-AmDH, LE-AmDH-v1; see Table <ref type="table" target="#tab_7">5</ref>.7 for enzyme sources and references for the plasmids) ‚Ä¢ E. coli cells harbouring the plasmid coding for the Cb-FDH (see Table <ref type="table" target="#tab_7">5</ref>.7) ‚Ä¢ Isopropyl-Œ≤-D-1-thiogalactopyranoside (IPTG stock 1 M) ‚Ä¢ Lysis buffer (pH 8.0, 50 mM KH 2 PO 4 , 300 mM NaCl, 10 mM imidazole) ‚Ä¢ Incubator for E. coli cell cultivation ‚Ä¢ Centrifuge ‚Ä¢ Eppifuge ‚Ä¢ OD 600 spectrophotometer ‚Ä¢ Precast sodium dodecyl sulfate (SDS)-based protein gels ‚Ä¢ Sample buffer, Laemmli 2√ó Concentrate (4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 0.004% bromophenol blue and 0.125 M Tris HCl, pH approx. 6.8) ‚Ä¢ Deionised water (dH 2 0)</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.6.1.2">Procedure</head><p>1. A sterilised LB medium (800 mL for cFL1-AmDH, 3√ó 800 mL for Rs-PhAmDH, LE-AmDH-v1 or Cb-FDH and 4√ó 800 mL for Bb-PhAmDH) supplemented with kanamycin (50 Œºg.mL -1 ) was inoculated with 15 mL (for each flask) of an overnight culture (150 mL) and cells were grown at 37 ‚àò C and 170 rpm until the OD 600 reached 0.7-1.0 (ca. 3 hr). The overnight culture was prepared by inoculating a single colony of transformed E.coli cells -harbouring the corresponding plasmid encoding for the AmDH or FDH -into 150 mL of LB media (sterilised) supplemented with kanamycin (50 Œºg.mL -1 ). The overnight culture was grown in an incubator at 37 ‚àò C and shaken at 170 rpm. 2. Overexpression of the AmDHs or Cb-FDH was induced by addition of IPTG (0.5 mM).</p><p>Flasks were shaken overnight at 25 ‚àò C and 170 rpm for cFL1-AmDH, Rs-PhAmDH, LE-AmDH-v1 and FDH and at 20 ‚àò C for Bb-PhAmDH. 3. The next day, cells were harvested by centrifugation at 4500 rpm and 4 ‚àò C for 20 min.</p><p>The cell pellets were washed by resuspension in a lysis buffer (pH 8.0) and centrifuged at 4500 rpm and 4 ‚àò C. The obtained cells were weighed (approx. 5 g of cells per 800 mL culture) and stored at -20 ‚àò C. 4. It is recommended that the level of enzyme expression by SDS-gel page be estimated as follows: a sample (1 mL) of the main culture was collected prior to induction with IPTG and the OD 600 was measured. From this sample, the volume (mL) equal to 1/(OD 600 √ó2) Table 5.6 (Continued) Compound Structure Conversion (%) a ee (%) 11a O F cFL1-AmDH (22%) 50/130/48 &gt;99 (R) LE-AmDH-v1 (92%) 50/90/48 &gt;99 (R) 12a O Cl Rs-PhAmDH (33%) 50/100/48 &gt;99 (R) 13a O F cFL1-AmDH (43%) 50/50/48 &gt;99 (R) LE-AmDH-v1 (96%) 50/90/48 &gt;99 (R) 14a O F LE-AmDH-v1 (98%) 50/90/48 &gt;99 (R) 15a H O LE-AmDH-v1 (&gt;99%) 50/90/48 N.A 16a O O LE-AmDH-v1 (55%) 50/90/48 &gt;99 (R) 17a O LE-AmDH-v1 (50%) 50/90/48 &gt;99 (R) 18a O LE-AmDH-v1 (84%) 50/90/48 N.A 19a O cFL1-AmDH (8%) 50/30/24 N.D. Rs-PhAmDH (4%) 50/50/24 N.D. (continued)</p><p>Table 5.6 (Continued) Compound Structure Conversion (%) a ee (%) 20a O cFL1-AmDH (75%) 50/130/48 &gt;99 (R) LE-AmDH-v1 (81%) 50/90/48 89 (R) 21a O cFL1-AmDH (92%) 50/30/24 &gt;99 (R) LE-AmDH-v1 (71%) 50/90/48 &gt;99 (R) 22a O cFL1-AmDH ( 98%) 50/30/24 &gt;99 (R) Rs-PhAmDH (99%) 50/50/24 &gt;99 (R) 23a O cFL1-AmDH (50%) 50/30/48 &gt;99 (R) Rs-PhAmDH (93%) 50/50/48 &gt;99 (R) 24a O cFL1-AmDH (96%) 50/130/48 &gt;99 (R) Rs-PhAmDH (91%) 50/130/48 &gt;99 R LE-AmDH-v1 (53%) 50/90/48 94 (R) 25a H O cFL1-AmDH (&gt;99%) 50/30/24 N.A. Rs-PhAmDH (99%) 50/130/48 N.A. 26a O cFL1-AmDH (57%) 50/90/48 &gt;99 (R) Rs-PhAmDH (32%) 50/100/48 &gt;99 (R) 27a O Rs-PhAmDH (99%) 50/130/48 &gt;99 (R) 28a O Rs-PhAmDH (71%) 50/100/48 &gt;99 (R) 29a O Rs-PhAmDH (87%) 50/100/48 &gt;99 (R) 30a O Rs-PhAmDH (&gt;99%) 50/50/24 &gt;99 (R) 31a H O Rs-PhAmDH (96%) 50/100/48 N.A. (continued)</p><p>Table 5.6 (Continued) Compound Structure Conversion (%) a ee (%) 32a O cFL1-AmDH (8%) 50/90/48 N.D LE-AmDH-v1 (95%) 50/90/48 &gt;99.9 (R) O 33a LE-AmDH-v1 (65%) 50/90/48 &gt;99 (R) O 34a LE-AmDH-v1 (26%) 50/90/48 N.D. 35a OH O O LE-AmDH-v1 (&gt;99%) 50/90/48 &gt;99 (S) 36a H OH O O LE-AmDH-v1 (&gt;99%) 50/90/48 N.A. 37a O LE-AmDH-v1 (&gt;99%) 20/90/48 &gt;99 (R)</p><p>a The three subscripts after the percentage denote substrate concentration (mM), enzyme concentration (ŒºM) and reaction time (hr), respectively. For Bb-PhAmDH, cFL1-AmDH and Rs-PhAmDH, the biocatalytic reactions were run at 30 ‚àò C, while for LE-AmDH-v1 at 50 ‚àò C. N.A., not applicable; N.D., not determined. Geobacillus sterothemophilus Œµ-L-lysine dehydrogenase [8] Cb-FDH Candida boidinii (wild-type) <ref type="bibr">[9]</ref> was transferred to an Eppendorf tube (1.5 mL) and centrifuged (14 000 rpm for 1 min). The cells were resuspended in 25 ŒºL of lysis buffer following addition of 25 ŒºL of sample buffer (sample I). Another sample (200 ŒºL culture + 800 ŒºL dH 2 O) was collected after the overnight induction and the OD 600 was measured. The total volume (mL), equal to 1/(OD 600 √ó2), was transferred to an Eppendorf tube and centrifuged (14 000 rpm for 1 min), then the cells were resuspended in 25 ŒºL of lysis buffer with the addition of 25 ŒºL of sample buffer (sample II). Equal amounts of sample I and sample II were run on an SDS-based protein gel to ensure comparable results. If the expression is accomplished successfully, it will be observed as a much thicker band for sample II compared with sample I (based on the enzyme's molecular weight). A higher enzyme expression level will result in a more intense SDS band for sample II.</p><p>5.6.2 Procedure 2: Purification of the Catalysts 5.6.2.1 Materials and Equipment ‚Ä¢ Lysis buffer (pH 8.0, 50 mM KH 2 PO 4 , 300 mM NaCl, 10 mM imidazole, filtered and degassed) ‚Ä¢ Wash buffer (pH 8.0, 50 mM KH 2 PO 4 , 300 mM NaCl, 25 mM imidazole, filtered and degassed) ‚Ä¢ Elution buffer (pH 8.0, 50 mM KH 2 PO 4 , 300 mM NaCl, 300 mM imidazole, filtered and degassed) ‚Ä¢ Phosphate buffer (pH 8.0, 50 mM) ‚Ä¢ 0.45 Œºm Syringe Filter Whatman ¬Æ ‚Ä¢ Ultrasonicator ‚Ä¢ Beckman J2-21 centrifuge (for lysate) ‚Ä¢ Eppendorf 5430R centrifuge for Vivaspin ¬Æ ‚Ä¢ Centrifuge tubes Oakridge style ‚Ä¢ NTA HisTrap FF columns (GE Healthcare Life Sciences) ‚Ä¢ Peristaltic pump ‚Ä¢ Vivaspin ¬Æ centrifugal concentrator ‚Ä¢ Dialysis tubes 5.6.2.2 Procedure 1. Cell pellets were defrosted and resuspended in a lysis buffer (5-10 mL of lysis buffer per gram of cell pellet). 2. The mixture containing E. coli cells was disrupted by sonication (amplitude = 45%;</p><p>pulse on = 10 sec; pulse off = 10 sec; total sonication time = 10-20 min). Sonication was performed until the suspension became darker and less viscous. During and after sonication, the enzyme solutions were kept cooled in an ice bath in order to minimise any possible partial loss of enzymatic activity. 3. The disrupted cells were centrifuged at 16 000 rpm and 4 ‚àò C for 60 min (Beckman J2-21 centrifuge). 4. The supernatant was collected and filtered through a 0.45 Œºm filter. Small samples of the pellet (insoluble part) and the filtrate (soluble part) were taken for SDS-PAGE analysis (see Procedure 1, Step 4).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.">Protein purification was performed by column chromatography using prepacked</head><p>Ni-NTA His trap TM HP columns (5 mL, 1 column volume, CV) according to the manufacturer's instructions. All solutions utilised during chromatography had first been filtered and degassed for 1 hr. The column was washed with dH 2 O (5 CV, 25 mL) and conditioned with a lysis buffer (10 CV, 50 mL), then the filtered supernatant was loaded into the column. The column was washed with a lysis buffer (5 CV, 25 mL) and sufficient amounts of washing buffer (ca. 50 mL, 10 CV). The bound protein was recovered with an elution buffer (ca. 25 mL, aliquots of 5 mL each). 6. Note: All washing and elution fractions were analysed by SDS-PAGE. Each sample to be analysed by SDS should be diluted twice with a sample buffer (Laemmli 2√ó Concentrate) 7. Pure fractions containing sufficient purified protein were pooled and dialysed overnight against potassium phosphate buffer (50 mM, pH 8.0, 8 L) at 4 ‚àò C. 8. The pooled protein solution was concentrated using a Vivaspin ¬Æ centrifugal concentrator (centrifuge: Eppendorf 5430R) to a volume of 5-10 mL.</p><p>5.6.3 Procedure 3: Determination of the Concentration of the Catalysts 5.6.3.1 Materials and Equipment ‚Ä¢ Potassium phosphate buffer (pH 8.0, 50 mM) ‚Ä¢ UV-Vis spectrophotometer ‚Ä¢ Cuvettes for UV-Vis (1 cm path length) 5.6.3.2 Procedure 1. A 50 mM potassium phosphate buffer solution, pH 8.0 (1 mL), was transferred into a UV cuvette and a spectrum was measured from 200 to 800 nm in the UV-Vis spectrophotometer. This spectrum served as a 'blank'. 2. Pooled concentrated enzymatic solution (20 ŒºL) was added into the phosphate buffer (980 ŒºL, 50 mM, pH 8.0; final dilution 1 : 50). The mixture was transferred into a cuvette and the spectrum was recorded from 200 to 800 nm. 3. The enzyme concentration (M) was determined using the Lambert-Beer equation A 280</p><p>= Œµ (M -1 .cm -1 ) √ó c (M) √ó l (cm) by considering the absorbance at 280 nm. At this point, the dilution of the enzyme (e.g. 50√ó) should be taken into consideration by multiplying the obtained value (M) by the dilution factor (e.g. 50). The mg.mL -1 of the enzyme can be calculated by multiplying the calculated M by the molecular weight of the enzyme. The extinction coefficients and the molecular weight of the enzymes are reported in Table <ref type="table" target="#tab_7">5</ref>.8. 4. The second step was repeated using different concentrations of the enzyme to verify the obtained results.</p><p>5.6.4 Procedure 4: Representative Asymmetric Reductive Amination Catalysed by AmDH on Preparative Scale 5.6.4.1 Materials and Equipment ‚Ä¢ Purified enzyme stock solution of Rs-PhAmDH (1.02 mL from 48.8 mg.mL -1 stock) ‚Ä¢ Purified enzyme stock solution of Cb-FDH (233 ŒºL from 80.7 mg.mL -1 stock) ‚Ä¢ NAD + (20 mg, 0.03 mmol) </p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.6.6">Conclusion</head><p>AmDHs enable the one-step conversion of ketones and aldehydes into amines, as shown in Table <ref type="table" target="#tab_7">5</ref>.6. The reductive amination of ketones resulted in enantiomerically pure Œ±-chiral amines (&gt;99% ee) possessing R configuration, the only exception being LE-AmDH-v1 with substrate 35a, which afforded the corresponding S-configured amine (&gt;99% ee). Substrates 20a (89% ee (R)) and 24a (94% ee (R)) were obtained with imperfect stereoselectivity. LE-AmDH-v1, Rs-PhAmDH, Bb-PhAmDH and cFL1-AmDH show complementary substrate scopes. On the one hand, LE-AmDH-v1can be used for the preparation of acetophenone (10a), acetophenone derivatives (9a, 11a, 13a, 14a) or bulky-bulky ketones such as 32-34a, in which the carbonyl moiety is adjacent to the phenyl group. Similarly, LE-AmDH-v1 can give access to 4-aminochromane (from 16a), 1-aminotetralin (from 17a) and 1-aminoindan (from 37a). On the other hand, Rs-PhAmDH, Bb-PhAmDH and cFL1-AmDH accept similar types of substrates, but Rs-PhAmDH is the preferable biocatalyst for the preparation of amphetamines (1-6a). Notably, Rs-PhAmDH is active towards ketone substrates in which the carbonyl moiety is located two or three carbons away from the phenyl group (e.g. 27-31a). Finally, cFL1-AmDH is the preferable biocatalyst for the reductive amination of linear or branched aliphatic ketones possessing from five to eight carbons (e.g. 20-26a).</p><p>Large-scale reductive amination resulted in amine products possessing excellent chemical and optical purities, simplifying the workup procedure. In fact, the unreacted ketone can first be extracted under acidic conditions; after the change in pH to basic, the enantiomerically pure amine is extracted. The members and diversity of the AmDH family are expected to grow in the coming years, increasing their applicability towards the synthesis of more complex Œ±-chiral amines. Further information about the enzyme sources can be found in Table <ref type="table" target="#tab_7">5</ref>.7.</p><p>5. Knaus, T., B√∂hmer, W. and Mutti, F. G. (2017) Green Chemistry, 19, 453-463. 6. Bommarius, B.R., Schurmann, M. and Bommarius, A.S. (2014) ChemComm, 50, 14 953-14 955. 7. Ye, L.J., Toh, H.H., Yang, Y. et al. (2015) ACS Catalysis, 5, 1119-1122. 8. Tseliou, V., Knaus, T., Masman, M.F. et al. (2019) Nature Communications, 10, 3717. 9. Schutte, H., Flossdorf, J., Sahm, H. and Kula, M.-R. (1976) European Journal of Biochemistry, 62, 151-160. 5.7 Utilisation of Adenylating Enzymes for the Formation of N-Acyl Amides Shona M. Richardson, Piera M. Marchetti, Noor M. Kariem and Dominic J. Campopiano * School of Chemistry, University of Edinburgh, Edinburgh, UK</p><p>Although an abundantly used chemical conversion, current methods for amide bond formation from carboxylic acids are inefficient. They suffer from poor atom economy with stoichiometric amounts of coupling agents, harsh conditions and the production of waste <ref type="bibr">[1]</ref><ref type="bibr">[2]</ref><ref type="bibr">[3]</ref>. However, the high polarity, stability and conformational diversity make them desirable functional groups <ref type="bibr">[4]</ref>. Enzymatic routes for amide bond formation bypass these restraints through the favoured reaction conditions of an aqueous environment with benign components. One such enzyme class is the amide bond synthetases (ABSs), a subgroup of which are members of the adenylating enzyme superfamily (ANLs). This diverse family of enzymes activate carboxylic acids for nucleophilic attack through a two-step catalytic reaction. First, a reactive acyl-adenylate intermediate is formed by condensing adenosine triphosphate (ATP) with the carboxylic acid. This intermediate is subsequently captured by the incoming amine nucleophile to form the desired amide product <ref type="bibr">[5]</ref><ref type="bibr">[6]</ref><ref type="bibr">[7]</ref><ref type="bibr">[8]</ref><ref type="bibr">[9]</ref><ref type="bibr">[10]</ref>. Figure <ref type="figure" target="#fig_10">5</ref>.2 shows the differences between the chemical and biocatalytic methods of amide bond formation, emphasising the requirement for an additional coupling reagent in the case of the chemical reaction. Using a biocatalyst as an alternative synthetic strategy has its own drawbacks, however, with the rigid substrate specificity limiting the enzymatic applications. Recent investigations into our enzyme of interest, Pseudoalteromonas tunicata TamA, a member of the ANL superfamily, have shown significant promiscuity with respect to the fatty acid (FA) and amine substrates, making this enzyme an ideal new member of the biocatalyst toolbox <ref type="bibr">[11,</ref><ref type="bibr">12]</ref>. Here, we describe the experimental details that show how TamA can be used to screen a range of FA and amino acid substrates and to prepare a series of N-acyl amides such as the N-C 4. The reactants were shaken at 37 ‚àò C and 250 rpm for 24 hours. 5. The reaction was stopped by the addition of an equal volume of acetonitrile with TFA (1 mL) -use 0.1% TFA for high-performance liquid chromatography (HPLC) analysis or 0.01% TFA for liquid chromatography electrospray ionisation-mass spectrometry (LC ESI-MS) analysis. 6. The samples were centrifuged at 13 300 rpm for 10 min. 7. The samples were analysed by HPLC and LC ESI-MS (Table <ref type="table" target="#tab_7">5</ref>.9 shows some of the accepted carboxylic acids and amines). 1. Dodecanoic acid (20 mg, 0.1 mmol) in a 4% w/v DMSO solution, ATP (132 mg, 0.24 mmol), MgCl 2 (190 mg, 2 mmol) and L-histidine (155 mg, 1 mmol) in a 100 mM solution of sodium carbonate/sodium bicarbonate buffer, pH 9.0 (50 mL) were added to a 250 mL flask to a final volume of 100 mL. 2. The reaction was initiated by the addition of the TamA ANL enzyme (1 mg, 1 mL). 3. Enzyme was continually added at 1 mg.hr -1 until a total of 5 mg had been added. 4. The reaction was shaken at 37 ‚àò C and 250 rpm. 5. After 24 hr, a white precipitate had formed, which was isolated by filtration and washed with water and ethanol to afford N-C 12 -L-histidine as a white precipitate (29 mg, 86%) (see Scheme 5.8). This was analysed on a 500 MHz Bruker NMR and by matrix assisted laser desorption ionisation, time of flight mass spectrometry (MALDI ToF) on a Bruker Ultraflex using 3,5-dimethoxy-4-hydroxy-cinnamic acid (sinapinic Acid) as the matrix.</p><p>ùõø H (500 MHz, DMSO-d 6 ) 7.90 (s,1H), 7.56 (d, J = 10, 1 H),6.74 (s, 1H), 4.35 (m, 1 H), 2.94 (m, 2H), 2.19 (t, J = 7.4, 2H), 2.06 (t, J = 7.5, 2H), 1.50 (t, J = 7.5 , 2H), 1.25 (s, 16 H), 0.86 (t, J = 2.5, 3 H). m/z (MALDI) for [C 18 H 31 N 3 O 3 ] + predicted: 338.24, observed: [M+H] + 338.239, 339.242 and 340.244. </p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>R 3 Scheme 5 . 1</head><label>351</label><figDesc>Scheme 5.1 Conversion of aniline derivatives to the corresponding acetanilides.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>5. 1 . 1</head><label>11</label><figDesc>Procedure 1: Biocatalytic Conversion of Aniline to Acetanilide5.1.1.1 Materials and Equipment‚Ä¢ 3-Aminophenol (21.8 mg, 0.2 mmol, Sigma-Aldrich #100242) ‚Ä¢ Potassium phosphate buffer (KPi-buffer; 100 mM, pH 7.5) ‚Ä¢ Cell-free extract containing the PpATaseCH (see Section 6.4) ‚Ä¢ Phenyl acetate (54.9 ŒºL, Sigma-Aldrich #108723) ‚Ä¢ Ethyl acetate (EtOAc) ‚Ä¢ Brine (NaCl-saturated solution) ‚Ä¢ Anhydrous Na 2 SO 4 ‚Ä¢ c-Hexane ‚Ä¢ Silica gel ‚Ä¢ TLC silica gel 60 F 254 aluminium plates (Merck) ‚Ä¢ 50 mL Falcon tube ‚Ä¢ 100 mL separating funnel ‚Ä¢ Orbital shaker (InforsHT Multitron 2 Standard) ‚Ä¢ Cooling centrifuge ‚Ä¢ Rotary evaporator (B√ºchi) ‚Ä¢ Potassium permanganate staining solution (1.5 g of KMnO 4 , 10 g of K 2 CO 3 and 1.25 mL of 10% NaOH in 200 mL of water) ‚Ä¢ Cerium sulfate staining solution (10% w/v solution of cerium (IV) sulfate in 15% sulfuric acid) 5.1.1.2 Procedure</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><figDesc>1 L, sterilised) ‚Ä¢ Sodium dodecyl sulfate (SDS) gels containing polyacrylamide (4-12%) ‚Ä¢ Lysis buffer (50 mM Tris-HCl, 300 mM NaCl, 20 mM imidazole, pH 8.0), 200 mL ‚Ä¢ Buffer A (50 mM Tris-HCl, 300 mM NaCl, 30 mM imidazole, pH 8.0), 200 mL ‚Ä¢ Buffer B (50 mM Tris-HCl, 300 mM NaCl, 500 mM imidazole, pH 8.0), 200 mL ‚Ä¢ Buffer C (20 mM Na 2 HPO 4 , pH 8.5), 500 mL ‚Ä¢ Centrifuge capable of reaching 15 000 rpm with temperature control ‚Ä¢ 50 mL conical-bottom centrifuge tube (CELLSTAR) ‚Ä¢ Quartz cuvette with 10 mm light path (Hellma Analytics) ‚Ä¢ Syringe filter, pore size 0.45 Œºm (Whatman) ‚Ä¢ HiLoad 16/600 Superdex 200 pg column (GE Healthcare Bio-Sciences AB) ‚Ä¢ Ni sepharose 6 fast-flow resin (GE Healthcare Bio-Sciences AB) ‚Ä¢ AKTA explorer 10S protein purification system ‚Ä¢ UV-VIS spectrophotometer ‚Ä¢ Vortex mixer ‚Ä¢ Rotary shaker with temperature control ‚Ä¢ 15 mL filter cartridges (Screening Devices BV) ‚Ä¢ 1.5 and 2 mL Eppendorf tubes ‚Ä¢ Magnetic stirrer ‚Ä¢ 3 L Erlenmeyer flask ‚Ä¢ Sterile loop ‚Ä¢ Sonicator (Branson Sonifier 450)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>1 H</head><label>1</label><figDesc>NMR (500 MHz, D 2 O): ùõø 3.94 (dd, J = 10.1, 3.4 Hz, 1H), 3.58-3.49 (m, 3H), 3.13-3.07 (m, 2H), 2.80 (dd, J = 17.4, 3.5 Hz, 1H), 2.60 (dd, J = 17.4, 10.0 Hz, 1H), 2.43-2.33 (m, 2H), 1.96-1.85 (m, 2H).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>‚Ä¢</head><figDesc>Tetrahydro-2H-pyran-4-amine 5b (202 mg, 2 mmol; Sigma-Aldrich) ‚Ä¢ Fumaric acid 2 (0.2 mmol, 200 ŒºL of 1 M stock solution in 20 mM Na 2 HPO 4 buffer, pH 8.5) ‚Ä¢ EDDS lyase in 20 mM Na 2 HPO 4 buffer (8.7 mg.mL -1 , 2 mL, pH 8.5) ‚Ä¢ Na 2 HPO 4 buffer (20 mM, pH 8.5, 50 mL) ‚Ä¢ NH 3 aqueous solution (2 M, 200 mL) ‚Ä¢ HCl aqueous solution (1 M, 200 mL) ‚Ä¢ HCl aqueous solution (2 M, 200 mL) ‚Ä¢ NaOH solution (1 M, 200 mL) ‚Ä¢ CuSO 4 aqueous solution (0.5 mM, 1 L) ‚Ä¢ Ninhydrin solution in EtOH (1 g.L -1 , 100 mL)</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><figDesc>-1 kanamycin ‚Ä¢ Isopropyl-Œ≤-D-1-thiogalactopyranoside (IPTG) ‚Ä¢ Potassium phosphate buffer pH 7.5 (50 mM) ‚Ä¢ Sodium phosphate buffer at pH 7.5 (50 mM) ‚Ä¢ Incubator ‚Ä¢ Water bath ‚Ä¢ 250 mL and 2 L Erlenmeyer flasks with baffles ‚Ä¢ Orbital shaker ‚Ä¢ Centrifuge ‚Ä¢ Spectrophotometer ‚Ä¢ Retsch Mixer Mill MM 200 ‚Ä¢ Glass beads (√ò 0.25-0.5 mm) ‚Ä¢ Chromatography equipment ‚Ä¢ Talon ¬Æ resin ‚Ä¢ Zeba spin columns 5.3.1.2 Procedure 1. The argininosuccinate lyase gene ARG4 was derived from Saccharomyces cerevisiae</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>5. 4 . 1 Scheme 5 . 5</head><label>4155</label><figDesc>Scheme 5.5 Synthesis of 3'-deoxyriboside 6-methoxyguanine (6-O-Me-Gua-3'-dR).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Figure 5 . 1</head><label>51</label><figDesc>Figure 5.1 1H-NMR spectrum.</figDesc><graphic coords="22,76.50,239.60,213.82,71.42" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>1 H</head><label>1</label><figDesc>NMR (700 MHz, DMSO-d6): ùõø = 8.10 (s, 1 H, H-2), 6.42 (br. sing., 2 H, NH), 5.77 (d, J = 2.23 Hz, 1 H, H-1'), 5.57 (br. d, J = 2.59 Hz, 1 H, OH-2'), 4.98 (br. t, J = 4.9 Hz, 1 H, OH-5'), 4.49 (m, 1 H, H-2'), 4.31 (m, 1 H, H-4'), 3.97 (s, 3 H, OCH 3 ), 3.66 (ddd, J = 11.8, 3.8, 3.9 Hz, 1 H, H-5a'), 3.51 (ddd, J = 11.9, 4.2, 4.3 Hz, 1 H, H-5b'), 2.24 (ddd, J = 14.6, 9.0, 5.8 Hz, 1 H, H-3a'), 1.90 (ddd, J = 13.2, 6.2, 2.9 Hz, 1 H, H-3b') (see Figure 5.1). 13 C NMR (176 MHz, DMSO-d6): ùõø = 160.58 (C6), 159.71 (C2), 153.60 (C4), 137.52 (C8), 113.84 (C5), 89.97 (C1'), 80.42 (C4'), 74.62 (C2'), 62.52 (C5'), 53.09 (OCH 3 ), 34.33(C3'). 15 N NMR (71 MHz, DMSO-d6): ùõø = 240.90 (N7), 205.59 (N1), 188.44 (N3) 170.3 (N9), 81.32 (NH 2 ).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Scheme 5 . 6 5 . 5 . 1 Procedure 1 :. 1 ) 5 .‚Ä¢</head><label>56551115</label><figDesc>Scheme 5.6 Ammonia elimination reaction of p-CH 3 -phenylalanine rac-1a and ammonia addition to p-Br-cinnamic acid 2b catalysed by E. coli whole cells harbouring the plasmid carrying the gene of PcPAL I460V.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_10"><head>5 L</head><label>5</label><figDesc>Erlenmeyer flask (baffled) with cotton cap ‚Ä¢ Incubator (New Brunswick Innova 40 Benchtop Incubator Shaker) ‚Ä¢ Vortex mixer (Ika Vortex Genius 3) 5.5.2.2 Procedure 1. (a) The substrate solution was prepared by dissolving rac-p-CH 3 -phenylalanine (100 mg) in 0.1 M NH 4 OH buffer (112 mL, pH 9.5, adjusted with CO 2 in dH 2 O) to give a final substrate concentration of 5 mM. (b) p-Br-Cinnamic acid (500 mg) was added to aqueous NH 4 OH (220 mL 6 M, pH 9.5, adjusted with CO 2 in dH 2 O) to give a final substrate concentration of 10 mM. 2. The E. coli cell pellets harbouring the plasmid with the pcpal I460V gene, prepared by Procedure 1, were gently resuspended in the correspondingly prepared substrate solution. (a) A 5 mM solution of rac-1a (112 mL) and cell pellet obtained from 47 mL bacterial culture of final OD 600 ‚àº6 is required to obtain a biocatalyst density of OD 600 ‚àº2.5 within the reaction volume. (b) A 10 mM solution of 2b (220 mL) and cell pellet obtained from 366 mL bacterial culture of final OD 600 ‚àº6 is required to reach the optimal biocatalyst cell density of OD 600 ‚àº10. 3. The reactions were incubated at 200 rpm, 30 ‚àò C for 48 hr. Conversion values were monitored by reversed-phase high-performance liquid chromatography (HPLC) (Procedure 3).</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_11"><head>a</head><figDesc>Mobile phase: A: NH 4 OH buffer (0.1 M, pH 9.0); B: MeOH; flow rate: 1.0 mL.min -1 , measurements performed at 25 ‚àò C using Gemini NX-C18 column (150 √ó 4.5 mm; 5 Œºm). b The relative response factor of the cinnamic acid derivatives 2a,b compared to the corresponding amino acids 1a,b was determined by injecting samples from their mixture solutions of controlled molar ratio of rac-1a(b) : 2a(b), ranging from 1 : 100 to 100 : 1.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_12"><head>5 . 7 . 1 Procedure 1 :Figure 5 . 2 1 .</head><label>5711521</label><figDesc>Figure 5.2 Comparison of the chemical and biocatalytic routes to the synthesis of amides. Highlighted are the structures of the common coupling agents used in chemical synthesis and the N-C 12 -L-histidine amide target synthesised using the TamA biocatalyst. ‚Ä¢ Sodium carbonate/bicarbonate buffer (1 : 8) (200 mM, pH 9.0) ‚Ä¢ ATP stock (31.5 mM) ‚Ä¢ MgCl 2 stock (100 mM) ‚Ä¢ Acetonitrile (with 0.01/0.1% triflouroacetic acid, TFA) ‚Ä¢ Thermoshaker ‚Ä¢ 1.5 mL Eppendorf flask 5.7.1.2 Procedure 1. To a 1.5 mL Eppendorf, 500 ŒºL of sodium carbonate/bicarbonate buffer (200 mM, pH 9.0) was added. 2. The rest of the reaction components were added to final concentrations of: fatty acid, 1 mM, 40 ŒºL, 4% DMSO; ATP, 5 mM, 160 ŒºL; MgCl 2 , 10 mM, 100 ŒºL; and amine, pH 9.0, 100 mM, 100 ŒºL. 3. The reaction was initiated by the addition of the enzyme (10 Œºg.mL -1 final, 100 ŒºL) to give a final reaction volume of 1 mL.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_13"><head>5. 7 . 2 Procedure 2 :</head><label>722</label><figDesc>Preparative-Scale Synthesis of the N-C12 -L-Histidine Amide Using Recombinant TamA ANL 5.7.2.1 Materials and Equipment ‚Ä¢ Purified recombinant TamA ANL domain from P. tunicata expressed in E. coli BL21 (DE3) using plasmid pET-HisTev_TamA ANL (expressed and purified as reported in [12]) ‚Ä¢ Dodecanoic acid stock (20 mg in 4 mL) in DMSO ‚Ä¢ Sodium carbonate/bicarbonate buffer (200 mM, pH 9.0, 50 mL) ‚Ä¢ ATP stock solution (132 mg in 16 mL water) ‚Ä¢ MgCl 2 stock solution (190 mg in 20 mL water) ‚Ä¢ Histidine stock solution (155 mg in 10 mL water, pH 9.0) ‚Ä¢ Acetonitrile (0.01/0.1% TFA) ‚Ä¢ Thermoshaker ‚Ä¢ 250 mL flask ‚Ä¢ Ethanol 5.7.2.2 Procedure</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_7"><head>Table 5 .1</head><label>5</label><figDesc>Enantioselective synthesis of N-heterocycloalkyl-substituted L-aspartic acids via the addition of amines 5a,b to fumarate catalysed by EDDS lyase.</figDesc><table><row><cell></cell><cell>HO 2 C</cell><cell>2</cell><cell>CO 2 H</cell><cell>+</cell><cell>5 a -b R NH 2</cell><cell>EDDS lyase condition a</cell><cell>HO 2 C</cell><cell>HN 6a-b</cell><cell>CO 2 H R</cell></row><row><cell>Entry</cell><cell cols="2">amines</cell><cell></cell><cell></cell><cell cols="2">Product</cell><cell cols="3">Conv. b (yield) c (%)</cell><cell>ee d (%)</cell></row><row><cell>H 2 N</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>HOOC</cell><cell>COOH</cell><cell></cell><cell></cell></row><row><cell>1</cell><cell>NH</cell><cell></cell><cell>5a</cell><cell></cell><cell>HN</cell><cell></cell><cell>6a</cell><cell cols="2">91 (67)</cell><cell>&gt;99</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>NH</cell><cell></cell><cell></cell></row><row><cell>H 2 N</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>HOOC</cell><cell>COOH</cell><cell></cell><cell></cell></row><row><cell>2</cell><cell>O</cell><cell></cell><cell>5b</cell><cell></cell><cell>HN</cell><cell>O</cell><cell>6b</cell><cell cols="2">84 (41)</cell><cell>&gt;99</cell></row><row><cell cols="10">a Reaction conditions: the reaction mixture (20 mL) consisted of fumaric acid 2 (10 mM),</cell></row><row><cell cols="10">amines 5a,b (100 mM) and EDDS lyase (0.15 mol% based on fumaric acid) in buffer</cell></row><row><cell cols="10">(20 mM Na 2 HPO 4 , pH 8.5), and was incubated at room temperature for 7 days.</cell></row></table><note><p>b Conversions were determined using 1H NMR spectroscopy. c Isolated yield after purification.</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_13"><head>Table 5 . 2</head><label>52</label><figDesc>Retention times for HPLC analysis.</figDesc><table><row><cell>Substance</cell><cell>Retention time</cell><cell>Percentage of components</cell><cell>Percentage of</cell></row><row><cell></cell><cell>(min)</cell><cell>before addition of</cell><cell>components 1.5 h</cell></row><row><cell></cell><cell></cell><cell>sodium arsenate</cell><cell>after addition</cell></row><row><cell></cell><cell></cell><cell></cell><cell>of sodium arsenate</cell></row><row><cell>Hyp</cell><cell>5.54</cell><cell>22.89</cell><cell>32.09</cell></row><row><cell>Ino</cell><cell>6.06</cell><cell>7.75</cell><cell>1.08</cell></row><row><cell>3'-dI</cell><cell>6.64</cell><cell>45.34</cell><cell>42.84</cell></row><row><cell>6-O-Me-Gua</cell><cell>9.08</cell><cell>1.99 (8.27) a</cell><cell>3.80 (15.38) a</cell></row><row><cell>6-O-Me-Gua-Rib</cell><cell>9.46</cell><cell>3.24 (13.48)</cell><cell>0.46 (1.92)</cell></row><row><cell>6-O-Me-Gua-3'-dR</cell><cell>9.92</cell><cell>18.82 (78.25)</cell><cell>19.74 (82.70)</cell></row></table><note><p>a Percentages in brackets reflect content of 6-O-Me-Gua and corresponding nucleosides only. HPLC was performed on HPLC System Waters Breeze (Waters 1525, Waters 2487, Breeze 2). Eluent A: 20% MeOH/H 2 O. Eluent B: MeOH. Detection at 260 nm. Elution: 0-100% B, 15 min, flow rate 0.5 mL.min -1 .</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_16"><head>Table 5 .</head><label>5</label><figDesc>3 HPLC methods for the monitoring of enzymatic reactions (determination of conversion values) and for the assessment of the enantiomeric excess (ee) of the products.</figDesc><table><row><cell>Compound</cell><cell>Eluent a (% B)</cell><cell cols="2">Retention</cell><cell>Response</cell><cell>Wavelength of</cell></row><row><cell></cell><cell></cell><cell cols="2">time (min)</cell><cell>factor b</cell><cell>UV detection</cell></row><row><cell></cell><cell></cell><cell>1</cell><cell>2</cell><cell>2vs. rac-1</cell><cell></cell></row><row><cell>1a, 2a</cell><cell>25-40/8 min</cell><cell>5.0</cell><cell>8.3</cell><cell>3.43</cell><cell>220</cell></row><row><cell>1b, 2b</cell><cell>35-50/6 min</cell><cell>5.7</cell><cell>8.5</cell><cell>1.59</cell><cell>220</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_17"><head>Table 5 .</head><label>5</label><figDesc>4 HPLC methods for the determination of the enantiomeric excess (ee) values of the D-and L-amino acid products.</figDesc><table><row><cell cols="5">Compound Eluent a (% B) Flow (mL.min -1 ) Retention</cell></row><row><cell></cell><cell></cell><cell></cell><cell cols="2">time (min)</cell></row><row><cell></cell><cell></cell><cell></cell><cell>D-1</cell><cell>L -1</cell></row><row><cell>rac-1a</cell><cell>20</cell><cell>0.4</cell><cell>4.3</cell><cell>9.1</cell></row><row><cell>rac-1b</cell><cell>30</cell><cell>0.4</cell><cell>3.7</cell><cell>7.2</cell></row><row><cell cols="5">a Mobile phase: A: aqueous HClO 4 (pH 1.5); B: ACN, measurements performed at 25 ‚àò C using Crownpak CR-I (+) column.</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_18"><head>Table 5 . 5</head><label>55</label><figDesc>Reaction time, conversion, isolation yield and enantiomeric excess (ee) values of the preparative-scale enzymatic reactions.</figDesc><table><row><cell>Substrate</cell><cell></cell><cell>PcPAL</cell><cell>Reaction</cell><cell>c (%)</cell><cell>Isolation</cell><cell>ee (%)</cell></row><row><cell></cell><cell></cell><cell>variant</cell><cell>time (hr)</cell><cell></cell><cell>yield (%)</cell></row><row><cell></cell><cell>COOH</cell><cell>I460V</cell><cell>30</cell><cell>50</cell><cell>74</cell><cell>95</cell></row><row><cell>H 3 C</cell><cell>NH 2</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>COOH</cell><cell>I460V</cell><cell>48</cell><cell>86</cell><cell>94</cell><cell>&gt;99</cell></row><row><cell>Br</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_21"><head>Table 5 . 6</head><label>56</label><figDesc>Substrates accepted by at least one of the reported AmDHs.</figDesc><table><row><cell>Compound</cell><cell cols="2">Structure</cell><cell>Conversion (%) a</cell><cell>ee (%)</cell></row><row><cell>1a</cell><cell>F</cell><cell>O</cell><cell>Bb-PhAmDH (93%) 50/50/48 cFL1-AmDH (93%) 50/30/24</cell><cell>&gt;99 (R) &gt;99 (R)</cell></row><row><cell>2a</cell><cell>O</cell><cell>O</cell><cell>cFL1-AmDH (&gt;99%) 50/130/48</cell><cell>&gt;99 (R)</cell></row><row><cell>3a</cell><cell></cell><cell>O</cell><cell>Rs-PhAmDH (98%) 50/50/24</cell><cell>&gt;99 (R)</cell></row><row><cell></cell><cell>O</cell><cell></cell><cell></cell><cell></cell></row><row><cell>4a</cell><cell>O</cell><cell>O</cell><cell>Rs-PhAmDH (&gt;99%) 50/50/24</cell><cell>&gt;99 (R)</cell></row><row><cell>5a</cell><cell></cell><cell>O</cell><cell>Rs-PhAmDH (98%) 50/130/48</cell><cell>&gt;99 (R)</cell></row><row><cell>6a</cell><cell></cell><cell>O</cell><cell>Rs-PhAmDH (98%) 50/130/48</cell><cell>&gt;99 (R)</cell></row><row><cell></cell><cell>CF 3</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H</cell><cell></cell><cell></cell></row><row><cell>7a</cell><cell></cell><cell>O</cell><cell>Bb-PhAmDH (34%) 50/50/48</cell><cell>N.A</cell></row><row><cell></cell><cell></cell><cell>O</cell><cell></cell><cell></cell></row><row><cell>8a</cell><cell></cell><cell></cell><cell>cFL1-AmDH (9%) 50/130/48</cell><cell>&gt;99 (R)</cell></row><row><cell></cell><cell cols="2">O</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>cFL1-AmDH (39%) 50/50/48</cell><cell>&gt;99 (R)</cell></row><row><cell>9a</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell></cell><cell>LE-AmDH-v1 (73%) 50/90/48</cell><cell>&gt;99 (R)</cell></row><row><cell></cell><cell cols="2">O</cell><cell>cFL1-AmDH (34%) 50/130/48</cell><cell>&gt;99 (R)</cell></row><row><cell>10a</cell><cell></cell><cell></cell><cell>LE-AmDH-v1 (&gt;99%) 50/90/48</cell><cell>&gt;99 (R)</cell></row><row><cell></cell><cell></cell><cell></cell><cell></cell><cell>(continued)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_25"><head>Table 5 . 7</head><label>57</label><figDesc>Enzyme sources.</figDesc><table><row><cell>Enzyme</cell><cell>Engineered from</cell><cell>Ref.</cell></row><row><cell>Bb-PhAmDH</cell><cell>Bacillus badius phenylalanine dehydrogenase</cell><cell>[4]</cell></row><row><cell>cFL1-AmDH</cell><cell>Chimeric enzyme</cell><cell>[6]</cell></row><row><cell>Rs-PhAmDH</cell><cell>Rhodococcus sp. M4 phenylalanine dehydrogenase</cell><cell>[7]</cell></row><row><cell>LE-AmDH-v1</cell><cell></cell><cell></cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_29"><head>Table 5 . 8</head><label>58</label><figDesc>Extinction coefficient (Œµ) at ùúÜ of 280 nm and molecular weight of the enzymes prepared using Procedure 3.Analytics for Determination of ConversionColumn: Agilent J&amp;W DB-1701 (30 m, 250 Œºm, 0.25 Œºm); carrier gas H 2 ; constant pressure 6.9 psi, split ratio 40 : 1, T injector 250 ‚àò C. Temperature program: T initial 60 ‚àò C, hold 6.5 min; gradient 20 ‚àò C.min -1 up to 100 ‚àò C, hold 1 min; gradient 20 ‚àò C.min -1 up to 280 ‚àò C, hold 1 min. C.min -1 up to 130 ‚àò C, hold 5 min; gradient 10 ‚àò C.min -1 up to 170 ‚àò C, hold 10 min; gradient 10 ‚àò C.min -1 up to 180 ‚àò C; hold 1 min.</figDesc><table><row><cell>Enzyme</cell><cell>Œµ (M -1 .cm -1 )</cell><cell>Molecular weight (kDa)</cell></row><row><cell>Bb-PhAmDH</cell><cell>25.000</cell><cell>43.5</cell></row><row><cell>cFL1-AmDH</cell><cell>21.100</cell><cell>43.6</cell></row><row><cell>Rs-PhAmDH</cell><cell>26.600</cell><cell>38.9</cell></row><row><cell>LE-AmDH-v1</cell><cell>17.900</cell><cell>44.6</cell></row><row><cell>Cb-FDH</cell><cell>51.400</cell><cell>42.4</cell></row><row><cell cols="2">‚Ä¢ Deionised water (dH 2 O, 30 mL)</cell><cell></cell></row><row><cell cols="2">‚Ä¢ Ammonium formate (1.90 g, 30 mmol)</cell><cell></cell></row><row><cell cols="3">‚Ä¢ Concentrated ammonia solution (6.4 M in dH 2 O, 0.274 mL)</cell></row><row><cell cols="3">‚Ä¢ p-Fluorophenyl-2-propanone 1a (50 mM, 195 ŒºL, 1.27 mmol)</cell></row><row><cell cols="2">‚Ä¢ Dimethyl sulfoxide (DMSO; 3 mL)</cell><cell></cell></row><row><cell>‚Ä¢ Round-bottom flask (100 mL)</cell><cell></cell><cell></cell></row><row><cell>‚Ä¢ HCl (1 M aqueous solution)</cell><cell></cell><cell></cell></row><row><cell>‚Ä¢ KOH (10 M aqueous solution)</cell><cell></cell><cell></cell></row><row><cell cols="2">‚Ä¢ Methyl tert-butyl ether (MTBE)</cell><cell></cell></row><row><cell>‚Ä¢ MgSO 4 (anhydrous)</cell><cell></cell><cell></cell></row><row><cell>‚Ä¢ Orbital shaker</cell><cell></cell><cell></cell></row><row><cell>5.6.4.2 Procedure</cell><cell></cell><cell></cell></row><row><cell cols="3">1. Ammonium formate (1.90 g, 30 mmol) was dissolved in dH 2 O (25 mL), and ammonia</cell></row><row><cell cols="3">solution (0.274 mL of a 6.4 M solution in dH 2 O) was added. The pH of the ammonium</cell></row><row><cell cols="3">formate buffer solution (ca. 1 M) was adjusted to 8.7 and dH 2 O was added to a total</cell></row><row><cell>volume of 30 mL.</cell><cell></cell><cell></cell></row><row><cell cols="3">2. Purified enzyme stocks of Rs-PhAmDH (49.8 mg, 43 ŒºM) and Cb-FDH (18.8 mg, 15</cell></row><row><cell cols="3">ŒºM) were added to the ammonium formate buffer (30 mL total volume, ca. 1 M, pH 8.7),</cell></row><row><cell cols="3">which contained NAD + (1 mM). p-Fluorophenyl-2-propanone 1a (195 ŒºL, 1.27 mmol,</cell></row><row><cell cols="3">50 mM) in DMSO (3 mL, 10% v/v) was added to the reaction mixture. The reaction was incubated at 30 ‚àò C, 180 rpm for 48 hr.</cell></row><row><cell cols="3">3. Workup was performed by acidification of the reaction mixture to pH 2-4 via addition of</cell></row><row><cell cols="3">1 M HCl (aq). The water layer was washed with MTBE (15 mL) to remove any possible</cell></row><row><cell cols="3">remaining ketone starting material. The pH of the reaction mixture was then increased (to</cell></row><row><cell cols="3">12-14) with 10 M KOH (aq), and the desired amine product was extracted with MTBE</cell></row><row><cell cols="3">(2√ó 15 mL). The organic layers were combined and dried over MgSO 4 . After filtration</cell></row><row><cell cols="3">and evaporation of the solvent, the desired product was obtained in a pure form. Column</cell></row><row><cell cols="3">chromatography was not required. The authenticity of the product was confirmed by</cell></row><row><cell>1 H-NMR.</cell><cell></cell><cell></cell></row><row><cell>5.6.5 Analytical Method</cell><cell></cell><cell></cell></row></table><note><p>1 </p><p>H NMR (400 MHz, CDCl 3 ): ùõø 7.12 (d, J = 8.6 Hz, 2H), 6.86 (d, J = 8.7 Hz, 2H), 3.81 (s, 3H), 3.13 (m, 1H), 2.67 (dd, J = 13.4, 5.3 Hz, 1H), 2.47 (dd, J = 13.4, 8.1 Hz, 1H), 1.12 (d, J = 6.3 Hz, 3H).</p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_32"><head>Table 5 . 9</head><label>59</label><figDesc>Panel of fatty acid and amine substrates used to screen the TamA-catalysed formation of N-acyl amides.</figDesc><table><row><cell cols="2">Fatty acid substrate</cell><cell cols="2">Amino acid substrate</cell><cell>Conversion (%)</cell></row><row><cell>O</cell><cell></cell><cell>N</cell><cell>NH</cell><cell>1</cell></row><row><cell>C 13 H 27</cell><cell>OH</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H 2 N</cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell>O</cell><cell></cell></row><row><cell>O</cell><cell></cell><cell>N</cell><cell>NH</cell><cell>5</cell></row><row><cell>C 12 H 25</cell><cell>OH</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H 2 N</cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell>O</cell><cell></cell></row><row><cell>O</cell><cell></cell><cell>N</cell><cell>NH</cell><cell>12</cell></row><row><cell>C 11 H 23</cell><cell>OH</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H 2 N</cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell>O</cell><cell></cell></row><row><cell>O</cell><cell></cell><cell>N</cell><cell>NH</cell><cell>19</cell></row><row><cell>C 11 H 23</cell><cell>OH</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H 2 N</cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell>O</cell><cell></cell></row><row><cell>O</cell><cell></cell><cell>N</cell><cell>NH</cell><cell>15</cell></row><row><cell>C 10 H 21</cell><cell>OH</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H 2 N</cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell>O</cell><cell></cell></row><row><cell>O</cell><cell></cell><cell>N</cell><cell>NH</cell><cell>34</cell></row><row><cell>C 9 H 19</cell><cell>OH</cell><cell></cell><cell></cell></row><row><cell></cell><cell></cell><cell>H 2 N</cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell>O</cell><cell></cell></row><row><cell>O</cell><cell></cell><cell></cell><cell>O</cell><cell>6</cell></row><row><cell>C 11 H 23</cell><cell>OH</cell><cell>S</cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell cols="2">NH 2</cell></row><row><cell>O</cell><cell></cell><cell>O</cell><cell></cell></row><row><cell>C 11 H 23</cell><cell>OH</cell><cell></cell><cell>OH</cell></row><row><cell></cell><cell></cell><cell>NH</cell><cell></cell></row></table></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div><p>acyl-adenylate) is not enzyme-catalysed. Future work could see the use of P. tunicata <rs type="person">TamA ANL</rs> for the preparation of clinically useful amide targets [7]  and expansion of the substrate scope of the biocatalyst by structure-guided rationale engineering <ref type="bibr" target="#b63">[15]</ref> combined with high-throughput screening.</p></div>
			</div>			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Scheme 5. <ref type="bibr">8</ref> Preparative-scale synthesis of the N-C 12 -L-histidine amide using recombinant TamA ANL.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.7.3">Analytical Method</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.7.3.1">Product Analysis of N-acyl Amides by LC ESI-MS</head><p>‚Ä¢ Aliquots of the reaction (50 ŒºL) were periodically taken, quenched with an equal volume of acetonitrile (0.01% TFA), centrifuged at 13 300 rpm for 10 min, loaded on to a Synapt G2-Si Q-TOF (Waters) instrument and analysed via LC ESI-MS with a Phenomenex Jupiter C18 5 Œºm 300 √Ö LC column coupled to an ESI source. ‚Ä¢ Products were eluted using a gradient from 5% acetonitrile and 95% water with 0.1% formic acid to 95% acetonitrile over 30 min. The MS source was set at 120 ‚àò C, back pressure 2 mbar and sampling cone voltage 54 V. Extracted ion chromatograms (EICs) and masses were determined on MassLynx V4.1 software.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.7.3.2">HPLC to Determine Conversion with TamA ANL for the Formation of N-C 12 -L-Histidine</head><p>‚Ä¢ Authentic N-acyl-amino acid samples were chemically synthesised using the coupling agent T3P <ref type="bibr">[13]</ref>, pyridine and DMF following published methods <ref type="bibr" target="#b62">[14]</ref>. Samples for HPLC analysis were prepared in a 1 : 1 volume of acetonitrile (0.1% TFA)/water. ‚Ä¢ Both authentic standards and reaction samples were centrifuged at 13 300 rpm for 10 min before 10 ŒºL of the supernatant was injected on to a Phenomenex Luna 5 Œºm C18 100 √Ö HPLC column. ‚Ä¢ Samples were eluted with water (0.1% TFA) for 5 min, followed by a 30 min gradient to 95% acetonitrile (0.1% TFA). This concentration was maintained for 5 min and then returned to 100% water (0.1% TFA) for 5 min. ‚Ä¢ The eluent was monitored at 210 nm.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5.7.4">Conclusion</head><p>Having tested both the promiscuity and the synthetic utility of the TamA ANL domain, this ATP-dependent enzyme has been shown to be a useful tool in the synthesis of a series of long-chain fatty amides (N-acyl amides). The TamA ANL biocatalyst displays a broad FA substrate scope for chain lengths C 10 -C 14 , presumably via the corresponding acyl-adenylate intermediate. The experimental data also confirms the ability of the enzyme to accept a range of amino acid substrates, including L-and D-histidine, which provides evidence to support the hypothesis that the second step of the mechanism (reaction of amine with</p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Pitman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Medicinal Research Reviews</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="189" to="214" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
	<note type="raw_reference">a) Pitman, I.H. (1981) Medicinal Research Reviews, 1, 189-214;</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Organic and Biomolecular Chemistry</title>
		<author>
			<persName><forename type="first">C</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mosbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Carey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Laffan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Thomson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Pitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Steiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dobrowolska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>K≈Çossowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Koszelewski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemistry: A European Journal</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page">689</biblScope>
			<date type="published" when="1997">1997. 2006. 2337. 2016. 2016</date>
		</imprint>
	</monogr>
	<note>Journal of Biotechnology Journal of Organic Chemistry</note>
	<note type="raw_reference">Yu, C. and Mosbach, K. (1997) Journal of Organic Chemistry, 62, 4057-4064; (c) Carey, J.S., Laffan, D., Thomson, C. and Williams, M.T. (2006) Organic and Biomolecular Chemistry, 4, 2337; (d) Pitzer, J. and Steiner, K. (2016) Journal of Biotechnology, 235, 32-46; (e) ≈ªa Àõd≈Ço-Dobrowolska, A., K≈Çossowski, S., Koszelewski, D. et al. (2016) Chemistry: A European Journal, 22, 16 684-16 689.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Advanced Synthesis &amp; Catalysis</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">T</forename><surname>Guranda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Van Langen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Van Rantwijk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Catalysis B: Enzymatic</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="2140" to="2147" />
			<date type="published" when="2001">2001. 2002. 2016. 2016</date>
		</imprint>
	</monogr>
	<note>Tetrahedron: Asymmetry Journal of the American Chemical Society</note>
	<note type="raw_reference">a) Guranda, D.T., van Langen, L.M., van Rantwijk, F. et al. (2001) Tetrahedron: Asymmetry, 12, 1645-1650; (b) Ulijn, R.V., Baraga√±a, B., Halling, P.J. and Flitsch, S.L. (2002) Journal of the American Chemical Society, 124, 10 988-10 989; (c) Kuo, C.H., Lin, J.A., Chien, C.M. et al. (2016) Journal of Molecular Catalysis B: Enzymatic, 129, 15-20; (d) Toplak, A., Nuijens, T., Quaedflieg, P.J. et al. (2016) Advanced Synthesis &amp; Catalysis, 358, 2140-2147;</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Land</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hendil-Forssell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martinelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Berglund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kazemi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Sheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kroutil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Himo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Catalysis Science &amp; Technology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="698" to="708" />
			<date type="published" when="2016">2016. 2018</date>
		</imprint>
	</monogr>
	<note>ACS Catalysis</note>
	<note type="raw_reference">Land, H., Hendil-Forssell, P., Martinelle, M. and Berglund, P. (2016) Catalysis Science &amp; Technology, 6, 2897-2900; (f) Kazemi, M., Sheng, X., Kroutil, W. and Himo, F. (2018) ACS Catalysis, 8, 10 698-10 706.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Pavkov-Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Richter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie International Edition</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="6057" to="6068" />
			<date type="published" when="2017">2017. 2017. 2018</date>
		</imprint>
	</monogr>
	<note>European Journal of Organic Chemistry Applied Microbiology and Biotechnology</note>
	<note type="raw_reference">a) Schmidt, N.G., Pavkov-Keller, T., Richter, N. et al. (2017) Angewandte Chemie International Edition, 56, 7615-7619; (b) Schmidt, N.G. and Kroutil, W. (2017) European Journal of Organic Chemistry, 39, 5865-5871; (c) Schmidt, N.G., ≈ªa Àõd≈Ço-Dobrowolska, A., Ruppert, V. et al. (2018) Applied Microbiology and Biotechnology, 102, 6057-6068.</note>
</biblStruct>

<biblStruct xml:id="b5">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>≈ªa Àõd≈Ço-Dobrowolska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kroutil</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
			<publisher>ChemComm</publisher>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="3387" to="3390" />
		</imprint>
	</monogr>
	<note type="raw_reference">≈ªa Àõd≈Ço-Dobrowolska, A., Schmidt, N.G. and Kroutil, W. (2018) ChemComm, 54, 3387 -3390. References</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>King</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Reid-Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">510</biblScope>
			<biblScope unit="page" from="503" to="506" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">King, A.M., Reid-Yu, S.A., Wang, W. et al. (2014) Nature, 510, 503-506.</note>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">Organic and Biomolecular Chemistry</title>
		<author>
			<persName><forename type="first">M</forename><surname>Maiti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Maiti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rozenski</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="5158" to="5174" />
		</imprint>
	</monogr>
	<note type="raw_reference">Maiti, M., Maiti, M., Rozenski, J. et al. (2015) Organic and Biomolecular Chemistry, 13, 5158-5174.</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">C</forename><surname>Mcilwain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Vandenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Ryan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="6801" to="6810" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McIlwain, B.C., Vandenberg, R.J. and Ryan, R.M. (2016) Biochemistry, 55, 6801-6810.</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Chattopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Raychaudhuri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chakraborty</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Food Science and Technology</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="611" to="621" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Chattopadhyay, S., Raychaudhuri, U. and Chakraborty, R. (2014) Journal of Food Science and Technology, 51, 611-621.</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">S</forename><surname>Piispanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Pihko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Tetrahedron Letters</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="2751" to="2755" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Piispanen, P.S. and Pihko, P.M. (2005) Tetrahedron Letters, 46, 2751-2755.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Boros</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>K√∂k√∂si</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>V√°mos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Amino Acids</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="709" to="717" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Boros, M., K√∂k√∂si, J., V√°mos, J. et al. (2007) Amino Acids, 33, 709-717.</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">F</forename><surname>Parmeggiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Weise</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Turner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemical Reviews</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="page" from="73" to="118" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Parmeggiani, F., Weise, N.J., Ahmed, S.T. and Turner, N.J. (2018) Chemical Reviews, 118, 73-118.</note>
</biblStruct>

<biblStruct xml:id="b13">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Y.-P</forename><surname>Xue</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C.-H</forename><surname>Cao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y.-G</forename><surname>Zheng</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
			<publisher>Chemical Society Reviews</publisher>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1516" to="1561" />
		</imprint>
	</monogr>
	<note type="raw_reference">Xue, Y.-P., Cao, C.-H. and Zheng, Y.-G. (2018) Chemical Society Reviews, 47, 1516-1561.</note>
</biblStruct>

<biblStruct xml:id="b14">
	<monogr>
		<title level="m" type="main">Advanced Synthesis &amp; Catalysis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Tepper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Poelarends</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019">2019</date>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="2433" to="2437" />
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang, J., Fu, H., Tepper, P.G. and Poelarends, G.J. (2019) Advanced Synthesis &amp; Catalysis, 361, 2433-2437.</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Poddar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>De Villiers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochemistry</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="3752" to="3763" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Poddar, H., de Villiers, J., Zhang, J. et al. (2018) Biochemistry, 57, 3752-3763.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Waddell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Laboratory and Clinical Medicine</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="311" to="314" />
			<date type="published" when="1956">1956</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Waddell, W.J. (1956) Journal of Laboratory and Clinical Medicine, 48, 311-314.</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saifuddin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Catalysis</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="page" from="186" to="191" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fu, H., Zhang, J., Saifuddin, M. et al. (2018) Nature Catalysis, 1, 186-191.</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Prats Luj√°n</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bothof</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Catalysis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="7292" to="7299" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fu, H., Prats Luj√°n, A., Bothof, L. et al. (2019) ACS Catalysis, 9, 7292-7299. References</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">B</forename><surname>Kusebauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Busch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Scherlach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie International Edition</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page" from="5001" to="5004" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kusebauch, B., Busch, B., Scherlach, K. et al. (2009) Angewandte Chemie International Edition, 48 (27), 5001-5004.</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Miyanaga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Natural Product Reports</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="531" to="547" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Miyanaga, A. (2019) Natural Product Reports, 36 (3), 531-547.</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">X</forename><surname>Garrabou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">S</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">I</forename><surname>Wicky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hilvert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie International Edition</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="issue">19</biblScope>
			<biblScope unit="page" from="5386" to="5389" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Garrabou, X., Macdonald, D.S., Wicky, B.I. and Hilvert, D. (2018) Angewandte Chemie Inter- national Edition, 130 (19), 5386-5389.</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">L</forename><surname>Biewenga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saravanan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kunzendorf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Catalysis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="1503" to="1513" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Biewenga, L., Saravanan, T., Kunzendorf, A. et al. (2019) ACS Catalysis, 9, 1503-1513.</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Svedendahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jovanoviƒá</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fransson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Berglund</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ChemCatChem</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="252" to="258" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Svedendahl, M., Jovanoviƒá, B., Fransson, L. and Berglund, P. (2009) ChemCatChem, 1 (2), 252-258.</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Steunenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sijm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Zuilhof</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Organic Chemistry</title>
		<imprint>
			<biblScope unit="volume">78</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="3802" to="3813" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Steunenberg, P., Sijm, M., Zuilhof, H. et al. (2013) Journal of Organic Chemistry, 78 (8), 3802-3813.</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">L.-H</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Dong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R.-J</forename><surname>Long</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Organic and Biomolecular Chemistry</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="807" to="812" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Du, L.-H., Dong, Z., Long, R.-J. et al. (2019) Organic and Biomolecular Chemistry, 17, 807-812.</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">B</forename><surname>Weiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Poelarends</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Janssen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Feringa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemistry: A European Journal</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">32</biblScope>
			<biblScope unit="page">100</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weiner, B., Poelarends, G.J., Janssen, D.B. and Feringa, B.L. (2008) Chemistry: A European Journal, 14 (32), 10 094-10 100.</note>
</biblStruct>

<biblStruct xml:id="b27">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">B</forename><surname>Schoenenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wszolek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Meier</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2017">2017</date>
			<publisher>RSC Advances</publisher>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">957</biblScope>
		</imprint>
	</monogr>
	<note type="raw_reference">Schoenenberger, B., Wszolek, A., Meier, R. et al. (2017) RSC Advances, 7, 48 952-48 957.</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Saifuddin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Catalysis</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="186" to="191" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fu, H., Zhang, J., Saifuddin, M. et al. (2018) Nature Catalysis, 1 (3), 186-191.</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Tepper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Poelarends</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Advanced Synthesis &amp; Catalysis</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2433" to="2437" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zhang, J., Fu, H., Tepper, P.G. and Poelarends, G.J. (2019) Advanced Synthesis &amp; Catalysis, 361 (11), 2433-2437.</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Prats Luj√°n</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bothof</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Catalysis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="7292" to="7299" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Fu, H., Prats Luj√°n, A., Bothof, L., et al. (2019) ACS Catalysis, 9, 7292-7299.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Hanahan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Molecular Biology</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="557" to="580" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hanahan, D. (1983) Journal of Molecular Biology, 166, 557-580. References</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>Krenitsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Koszalka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">V</forename><surname>Tuttle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Mikhailopulo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Miroshnikov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Fateev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kharitonova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Antonov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemistry: A European Journal</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">38</biblScope>
			<biblScope unit="page">419</biblScope>
			<date type="published" when="1981">1981. 2010. 2015</date>
		</imprint>
	</monogr>
	<note>Acta Naturae Biochemistry</note>
	<note type="raw_reference">a) Krenitsky, T.A., Koszalka, G.W. and Tuttle, J.V. (1981) Biochemistry, 20, 3615-3621; (b) Mikhailopulo, I. and Miroshnikov, A. (2010) Acta Naturae, 2, 36-58; (c) Fateev, I., Kharitonova, M., Antonov, K. et al. (2015) Chemistry: A European Journal, 21 (38), 13 401-13 419.</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Fateev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">V</forename><surname>Antonov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Konstantinova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Beilstein Journal of Organic Chemistry</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1555" to="1560" />
			<date type="published" when="1893">2014. 2002. 1893-1900. 2011</date>
		</imprint>
	</monogr>
	<note>Helvetica Chimica Acta</note>
	<note type="raw_reference">a) Fateev, I.V., Antonov, K.V., Konstantinova, I.D. et al. (2014) Beilstein Journal of Organic Chemistry, 10, 1657-1669; (b) Barai, V.N., Zinchenko, A.I., Eroshevskaya, L.A. et al. (2002) Helvetica Chimica Acta, 85, 1893-1900; (c) Konstantinova, I.D., Antonov, K.V., Fateev, I.V. et al. (2011) Synthesis, 10, 1555-1560.</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Konstantinova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Selezneva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Fateev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synthesis</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="272" to="276" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">a) Konstantinova, I.D., Selezneva, O.M., Fateev, I.V. et al. (2013) Synthesis, 45 (2), 272-276;</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">I</forename><surname>Kharitonova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Fateev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Kaushin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synthesis</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="394" to="406" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kharitonova, M.I., Fateev, I.V., Kaushin, A.L. et al. (2016) Synthesis, 48 (3), 394-406.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Konstantinova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Chudinov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Fateev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioorganic &amp; Medicinal Chemistry Letters</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="214" to="216" />
			<date type="published" when="2013">2013. 2016. 2016</date>
		</imprint>
	</monogr>
	<note>Russian Journal of Bioorganic Chemistry Mendeleev Communications</note>
	<note type="raw_reference">a) Konstantinova, I.D., Chudinov, M.V., Fateev, I.V. et al. (2013) Russian Journal of Bioor- ganic Chemistry, 39(1), 53-71; (b) Chudinov, M.V., Prutkov, A.N., Matveev, A.V. et al. (2016) Bioorganic &amp; Medicinal Chemistry Letters, 26, 3223-3225; (c) Chudinov, M.V., Matveev, A.V., Prutkov, A.N. et al. (2016) Mendeleev Communications, 26 (3), 214-216.</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Bzowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kulikowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Shugar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacology &amp; Therapeutics</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="349" to="425" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bzowska, A., Kulikowska, E. and Shugar, D. (2000) Pharmacology &amp; Therapeutics, 88, 349-425.</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">D</forename><surname>Konstantinova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Fateev</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Miroshnikov</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Russian Journal of Bioorganic Chemistry</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="372" to="380" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Konstantinova, I.D., Fateev, I.V. and Miroshnikov, A.I. (2016) Russian Journal of Bioorganic Chemistry, 42 (4), 372-380.</note>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>Denisova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">A</forename><surname>Tokunova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">V</forename><surname>Fateev</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synthesis</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="4853" to="4860" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Denisova, A.O., Tokunova, Y.A., Fateev, I.V. et al. (2017) Synthesis, 49, 4853-4860.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">S</forename><surname>Esipov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Gurevich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">V</forename><surname>Chuvikovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Protein Expression and Purification</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="56" to="60" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Esipov, R.S., Gurevich, A.I., Chuvikovsky, D.V. et al. (2002) Protein Expression and Purification, 24 (1), 56-60.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Z A</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Tork</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Lang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Catalysis</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="8825" to="8834" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Nagy, E.Z.A., Tork, S.D., Lang, P.A. et al. (2019) ACS Catalysis, 9, 8825-8834.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Filip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Z A</forename><surname>Nagy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Tork</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ChemCatChem</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="2627" to="2633" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Filip, A., Nagy, E.Z.A., Tork, S.D. et al. (2018) ChemCatChem, 10, 2627-2633.</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Bencze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Filip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>B√°n√≥czi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Organic and Biomolecular Chemistry</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="3717" to="3727" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bencze, L.C., Filip, A., B√°n√≥czi, G. et al. (2017) Organic and Biomolecular Chemistry, 15, 3717-3727.</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">T</forename><surname>Ahmed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Parmeggiani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Weise</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Catalysis</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="5410" to="5413" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note>References</note>
	<note type="raw_reference">Ahmed, S.T., Parmeggiani, F., Weise, N.J. et al. (2015) ACS Catalysis, 5, 5410-5413. References</note>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Abrahamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Vazquez-Figueroa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">B</forename><surname>Woodall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie International Edition</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="3969" to="3972" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Abrahamson, M.J., Vazquez-Figueroa, E., Woodall, N.B. et al. (2012) Angewandte Chemie Inter- national Edition, 51, 3969-3972.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Patil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grogan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bommarius</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Catalysis</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">15</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Patil, M.D., Grogan, G., Bommarius, A. and Yun, H. (2018) ACS Catalysis, 8, 10 985-11 015.</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">O</forename><surname>Mayol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bastard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Beloti</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Catalysis</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="324" to="333" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mayol, O., Bastard, K., Beloti, L. et al. (2019) Nature Catalysis, 2, 324-333.</note>
</biblStruct>

<biblStruct xml:id="b48">
	<monogr>
		<title level="m" type="main">Advanced Synthesis &amp; Catalysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Abrahamson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Bommarius</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2013">2013</date>
			<biblScope unit="volume">355</biblScope>
			<biblScope unit="page" from="1780" to="1786" />
		</imprint>
	</monogr>
	<note type="raw_reference">Abrahamson, M.J., Wong, J.W. and Bommarius, A.S. (2013) Advanced Synthesis &amp; Catalysis, 355, 1780-1786.</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">R</forename><surname>Pattabiraman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Bode</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">480</biblScope>
			<biblScope unit="page" from="471" to="479" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pattabiraman, V.R. and Bode, J.W. (2011) Nature, 480, 471-479.</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J</forename><surname>Pitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Steiner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Journal of Biotechnology</title>
		<imprint>
			<biblScope unit="volume">235</biblScope>
			<biblScope unit="page" from="32" to="46" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pitzer, J. and Steiner, K. (2016) Journal of Biotechnology, 235, 32-46.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Sabatini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">T</forename><surname>Boulton</surname></persName>
		</author>
		<author>
			<persName><forename type="middle">H F</forename><surname>Sneddon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Sheppard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Catalysis</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="10" to="17" />
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sabatini, M.T., Boulton, L.T., Sneddon. H.F. and Sheppard, T.D. (2019) Nature Catalysis, 2, 10-17.</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">K</forename><surname>Sasaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Crich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Organic Letters</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="2256" to="2259" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sasaki, K. and Crich, D. (2011) Organic Letters, 13, 2256-2259.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Gulick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">ACS Chemical Biology</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="811" to="827" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gulick, A.M. (2009) ACS Chemical Biology, 4, 811-827.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<monogr>
		<author>
			<persName><forename type="first">S</forename><surname>Schmelz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Naismith</surname></persName>
		</author>
		<title level="m">Current Opininion in Structural Biology</title>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="666" to="671" />
		</imprint>
	</monogr>
	<note type="raw_reference">Schmelz, S. and Naismith, J.H. (2009) Current Opininion in Structural Biology, 19, 666-671.</note>
</biblStruct>

<biblStruct xml:id="b55">
	<monogr>
		<title level="m" type="main">Advanced Synthesis and Catalysis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J B</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Diaz-Rodriguez</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019">2019</date>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="2421" to="2432" />
		</imprint>
	</monogr>
	<note type="raw_reference">Adams, J.P., Brown, M.J.B., Diaz-Rodriguez, A. et al. (2019) Advanced Synthesis and Catalysis, 361, 2421-2432.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Devine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Howard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kumar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Reviews Chemistry</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="409" to="421" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Devine, P.N., Howard, R.M., Kumar, R. et al. (2018) Nature Reviews Chemistry, 2, 409-421.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<monogr>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hughes</surname></persName>
		</author>
		<title level="m">Organic Process Research and Development</title>
		<imprint>
			<date type="published" when="2018">2018</date>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="574" to="584" />
		</imprint>
	</monogr>
	<note type="raw_reference">Hughes, D.L. (2018) Organic Process Research and Development, 22, 574-584.</note>
</biblStruct>

<biblStruct xml:id="b58">
	<monogr>
		<title level="m" type="main">Advanced Synthesis and Catalysis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Petchey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Grogan</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019">2019</date>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="3895" to="3914" />
		</imprint>
	</monogr>
	<note type="raw_reference">Petchey, M.R. and Grogan, G. (2019) Advanced Synthesis and Catalysis, 361, 3895-3914.</note>
</biblStruct>

<biblStruct xml:id="b59">
	<monogr>
		<title level="m" type="main">Organic and Biomolecular Chemistry</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Marchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Simpson</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2018">2018</date>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="2735" to="2740" />
		</imprint>
	</monogr>
	<note type="raw_reference">Marchetti, P.M., Kelly, V., Simpson, J.P. et al. (2018) Organic and Biomolecular Chemistry, 16, 2735-2740.</note>
</biblStruct>

<biblStruct xml:id="b60">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Marchetti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Richardson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Kariem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Campopiano</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2019">2019</date>
			<publisher>MedChem-Comm</publisher>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="1192" to="1196" />
		</imprint>
	</monogr>
	<note type="raw_reference">Marchetti, P.M., Richardson, S.M., Kariem, N.M. and Campopiano, D.J. (2019) MedChem- Comm, 10, 1192-1196.</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">B</forename><surname>Hosamani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Synthesis</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="1569" to="1601" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hosamani, B. (2013) Synthesis, 45, 1569-1601.</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">M</forename><surname>Petchey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cuetos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Rowlinson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Angewandte Chemie-International Edition</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page">588</biblScope>
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Petchey, M., Cuetos, A., Rowlinson, B. et al. (2018) Angewandte Chemie-International Edition, 57, 11 584-11 588.</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">J.-Y</forename><surname>Weng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X.-L</forename><surname>Bu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B.-B</forename><surname>He</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemical Communications</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page">843</biblScope>
			<date type="published" when="2019">2019</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Weng, J.-Y., Bu, X.-L., He, B.-B. et al. (2019) Chemical Communications, 55, 14 840-14 843.</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
